桔梗引经治疗慢性阻塞性肺疾病机理研究
|
摘要
慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)是一种常见的呼吸系统疾病,以气道炎症及气流阻塞为发病特点。桔梗作为手太阴肺经的引经药,在肺系疾病的治疗中常常配伍使用。本课题在文献、理论研究基础上,从实验角度观察桔梗作为引经药与清热解毒药物配伍后对COPD的治疗作用及作用机理,进一步探讨桔梗引经的作用机制。论文共分三部分:
第一部分文献综述。
系统综述了COPD的现代研究、中医药治疗概况、桔梗在呼吸系统的应用以及归经、引经理论的研究进展。
目前,COPD发病情况已在全球引起重视。全球许多学者围绕COPD病因学、发病机理、诊断、治疗等从实验和临床方面开展了大量研究工作,取得了一定的研究成果。大量研究显示,中医药通过其多靶点、多环节、多途径的调理作用在COPD的治疗中具有一定的优势。
归经、引经理论是中医药理论体系的重要组成部分,对中医临床用药发挥指导作用。近年来,许多学者尝试用现代理论、技术和方法对归经、引经进行研究,并取得了一定的成果,但仍未有重大突破,尚需结合相关领域的最新研究进展,不断地探索。
第二部分理论探讨。
梳理历代医家对归经、引经理论的认识,对常用引经药的功效及临床应用进行分析,探讨张仲景《伤寒杂病论》中有关归经、引经的学术思想。
中药归经、引经理论起于秦汉,在金元时代基本确立,明清时代渐趋完善。其中张仲景《伤寒杂病论》所创立的六经辨证与脏腑辨证体系为归经理论的形成奠定了基础。
引经药在方剂中能够引导其它药物的药力直达脏腑、经络等病变部位,使药效集中,从而提高疗效。历代医家认为桔梗是手太阴肺经的引经药,可为“诸药舟楫”。
第三部分实验研究。
目的:从病理形态学角度观察清热解毒药中配伍桔梗后对COPD的治疗作用。从炎症细胞、细胞因子角度探讨清热解毒药中配伍桔梗对COPD治疗作用的机理。从肺内生物活性肽肠三叶因子(trefoil factor family3,TFF3)、血管活性肠肽(vasoactive intestinal peptide,VIP)角度探讨引经机制。
方法:用熏香烟加气管注入脂多糖的联合造模方法建立大鼠COPD模型,将大鼠随机分为七组,即假手术组、模型组、桔梗组(桔梗)、桔甘组(桔梗、甘草)、银翘组(银花、连翘等)、桔银翘组(桔梗、银花、连翘等)、桔甘银翘组(桔梗、甘草、银花、连翘等)。假手术组、模型组灌胃生理盐水,各给药组灌胃相应中药,连续28天。取大鼠肺组织分别制作光镜、电镜标本。通过病理切片及半定量病理分析评价各给药组对COPD中的治疗效果。用ABC-ELISA法测定大鼠肺泡灌洗液(BALF)中IL-1β、TNF-α、TGF-β的含量并计数大鼠BALF中白细胞数量。用RT-PCR技术测定肺组织肠三叶因子(TFF3)mRNA表达。用放免法测定肺组织中血管活性肠肽(VIP)的含量。
结果及分析:
(1)模型组光镜下观察结果显示,大鼠肺泡结构破坏,局部肺泡萎陷,肺泡间隔明显增宽,甚至融合,肺泡壁和间质内有大量炎细胞浸润。支气管上皮明显增生,部分上皮脱落,管壁及其周围有明显炎细胞浸润。超微结构观察显示,大鼠肺泡Ⅱ型上皮细胞变性,细胞表面微绒毛减少、断裂甚或脱失,线粒体肿胀,嵴消失,甚至呈空泡样,肺泡腔内巨噬细胞次级溶酶体增多。半定量病理分析显示,肺平均内衬间隔(MLI)、平均肺泡数(MAN)较假手术组有显著性差异(P<0.01)。表明模型组的肺泡直径增大,单位面积上的肺泡数减少,肺泡结构破坏明显。
提示: COPD模型组镜下改变与假手术组相比具有明显差别,肺组织结构严重受损,炎症反应增多。
桔梗组、桔甘组、银翘组对COPD病理改变与模型组相比均无明显统计学差异。提示单味桔梗或单纯清热解毒药对COPD病变改善不明显。
桔银翘组即在清热解毒药中配伍桔梗,光镜下观察显示,病变范围缩小,程度减轻。炎性浸润明显减少,大部分肺泡结构基本恢复。超微结构显示,肺泡上皮细胞变性不明显,细胞结构多完整,线粒体结构正常,中性粒细胞、巨噬细胞等炎症细胞减少。半定量病理分析显示,肺平均内衬间隔(MLI)较模型组有显著差异(P<0.05),平均肺泡数(MAN)虽无统计学差异,但有一定升高趋势。说明桔银翘组能明显改善肺泡直径,在一定程度上增加肺泡数。
提示:桔银翘组与COPD模型组相比病理改变具有明显差异。清热解毒药中配伍桔梗对COPD的炎症反应、肺组织结构改变具有一定的改善作用,优于单味桔梗组和单纯清热解毒药组,说明桔梗在其中发挥了引经增效作用。
桔甘银翘组即在清热解毒药中配伍桔梗、甘草,光镜下观察显示,病变范围缩小,程度减轻。炎性浸润明显减少,大部分肺泡结构基本恢复。超微结构显示,桔甘银翘组肺泡上皮细胞变性不明显,细胞结构多完整,线粒体结构正常,中性粒细胞、巨噬细胞等炎症细胞减少。肺平均内衬间隔(MLI)较模型组有降低趋势,平均肺泡数(MAN)较模型组显著升高(P<0.01)。提示桔甘银翘组能明显增加单位面积上的肺泡数。对COPD病理状态下肺组织结构有一定恢复作用。
提示:桔甘银翘组与COPD模型组相比病理改变具有显著差异。清热解毒药中配伍桔梗、甘草对COPD的炎症反应、肺组织结构改变具有更明显的改善作用,说明桔梗、甘草配伍后发挥了配伍引经增效作用。
(2)模型组与假手术组相比白细胞总数、IL-1β、TNF-α、TGF-β含量升高,具有显著统计学差异(P<0.01,P<0.01,P<0.05,P<0.05),提示COPD病理模型的具有明显的炎症征象,这与上述病理切片结果相一致。
桔银翘组与模型组相比,白细胞总数、IL-1β有显著统计学差异(P<0.05,P<0.01),对TNF-α有一定降低趋势。说明桔银翘组能够在一定程度上减少COPD模型白细胞总数、IL-1β、TNF-α含量。提示桔银翘组改善COPD病理改变,发挥治疗作用可能与降低白细胞总数、IL-1β、TNF-α含量有关。
桔甘银翘组与模型组相比,白细胞总数、IL-1β、TNF-α、TGF-β含量均有降低,具有显著统计学差异(P<0.01,P<0.01,P<0.05,P<0.05)。提示桔甘银翘组能够在一定程度上减少白细胞总数、IL-1β、TNF-α、TGF-β含量,与桔甘银翘组改善COPD病理改变,发挥治疗作用有关。
(3)模型组TFF3基因表达、VIP含量较假手术组均呈降低趋势。表明COPD病理状态下这两种神经肽水平均有降低。各治疗组TFF3、VIP含量与模型组虽无统计学差异,但均有不同程度的上升趋势,其中以桔梗调节TFF3的变化趋势最大,推测桔梗的引经增效作用与调节TFF3有关,TFF3可能为桔梗的作用靶点之一。桔甘银翘组调节VIP变化趋势最大,推测桔梗、甘草的配伍引经效果与调节VIP有关。
结论:
清热解毒药物中配伍桔梗后,表现出一定的肺部引经增效作用,能够使清热解毒药物在肺部的治疗作用增加。这种引经增效作用机制可能与桔梗调节TFF3、VIP有关。配伍桔梗、甘草后表现出一定的配伍引经增效作用,其机制可能与调节VIP关系更为密切。
为进一步确定TFF3、VIP是否为桔梗引经增效作用的靶点,仍需采用多种检测方法从不同角度证实。
Chronic obstructive pulmonary disease (COPD) is a kind of familar respiratory disease, characterized by inflammation in air passage and obstruction of air flow.As a meridian guiding herb in Lung Meridian of Hand-Taiyin, Radix Platycodi is usually used in pulmonary disease.Base on the study of document and theory,we observe the therapeutic effect on COPD and its mechanism when Radix Platycodi as a meridian guiding herb,combined with heat-clearing and detoxicating herbs.Furthermore,we explore the mechanism of meridian guiding effect of Radix Platycodi.The thesis is totally divided into three parts:
The first part is literature review.
Summarize the modern research and therapeusis of Chinese medicine in COPD,the Radix Platycodi’application in respiratory system ,the researching progress in the theory of meridian tropism and guiding.
At present,the incidence of COPD is attached importance by many researchers in the world.Many people do a lot of experimental and clinical study work with COPD about etiology, pathogenesy, diagnosis, therapeusis ect.And these studies acquire many achievements.A great deal of researchs show that chinese medicine have some advantages on the treatment of COPD.Because they have effects on many targets, elements and pathways.
The theory of meridian tropism and guiding is one of the important part in Chinese medicine.It has directive effect on clinic.Recently years,many researchers attempt to study it using mordern theory, technique and methods.These studies obtained a certain progress, but have not grave breakthrough and still need explore it combining the latest researching progresses.
The second part is theoretical study.
Comb the understanding of Chinese doctors about the theory on meridian tropism and guiding in the history of Chinese medicine.Analyse the effect and clicical application of meridian guiding herbs.Explore academic ideology of Zhangzhongjing about the theory of meridian tropism and guiding in Treatise On Cold-Attack and Miscellaneous Disease.
The theory of meridian tropism and guiding was originated from Qin and Han dynasties, established in Jin and Yan dynasties, perfected in Ming and Qing Dynasties.The six meridian syndrome differentiation and visceral syndrome differentiation,which founded by Zhang zhongjing,were the foundation of the theory .
The meridian guiding herbs can lead other medicine to diseased region,concentrate drug action,improve the effect. Radix Platycodi is considered as a meridian guiding herb in Lung Meridian of Hand-Taiyin,possessing the floating effect. It is usually used in pulmonary disease.
The third part is experimental study.
Objective:Obsever the therapeutic effect of heat-clearing and detoxicating herbs compined with Radix Platycodi on COPD through pathomorphology.Explore the mechanism of the therapeutic effect through inflammatory cell and cytokine. Study the mechanism of meridian guiding through TFF3、VIP.
Methods:COPD rat model was induced by cigarette smoking inhalation and intratracheal LPS exposure.Rats were divided into 7 groups,namely normal group,model group, Jiegeng group(Radix Platycodi),Jiegan group(Radix Platycodi, Glycyrrhiza),Yinqiao group(Flos Lonicerae, Forsythia suspense, ect),Jieyinqiao group(Radix Platycodi,Flos Lonicerae, Forsythia suspense,ect),Jieganyinqiao group(Radix Platycodi,Glycyrrhiza,Flos Lonicerae, Forsythia suspense,ect). Normal group and model group were given saline,other groups were given corresponding herbal medicine, continuously for 28 days. Takeing lung tissue of rats, making specimen for optical microscope and electron microscope.
Measures the content of TNF-α,TGF-,IL-1βwith the ABC-ELISA method and count the quantity of white blood cell in BALF. Measures trefoil Factor Family3 (TFF3) mRNA expression on the lung with RT-PCR technique. Measures the content of vasoactive intestinal peptide (VIP) in the lung with radio-immunity methods.
Results and analysis:
The light-microscope observation show that in the model group ,the structure of bronchoalveolus is destructive,detelectasis and the interval is broaden, coalesce. There have many inflammatory cells infiltration in alveolar wall and interalveolar septum. Bronchial epithelium proliferate obviously.Some parts of epithelium are deciduous. Inflammatory cell infiltrate into bronchial wall.
The ultra-microstructure observation show that alveolar typeⅡepithelial cells degenerate, microvilli in the surface of cell deplete, fragmentation and deciduous. Mitochondria swelling, ridge disappearing. secondary lysosome of macrophagocyte increase.
Pathological semiquantitative analysis show that MLI、MAN have significant difference comparing with normal group(P<0.01).It manifest that alveolar diameter increased,the quantity of bronchoalveolus reduced,the structure of bronchoalveolus is detoryed obviously.
The results manifest that the changes in model group have significant difference comparing with normal group in microscope.The structure of lung tissue is distoryed severly,inflammatory reaction increased.
Jiegen group, Jiegan group,Yinqiao group have not obviously different on pathological changes comparing with model group.It manifest that when Radix Platycodi and heat– clearing and detoxicating herbs use separately ,the meliorative effect on pathological changes is not obviously.
Jieyinqiao group ,that is heat-clearing and detoxicating herbs combined with Radix Platycodi.The light-microscope observation show,the range of pathological changes reduce,the degree relieve.
The infiltration of inflammatory cell decrease obviously.The structure of bronchoalveolus recover mostly. The ultra-microstructure observation show,the change of alveolar typeⅡepithelial cells is not obviously.The structure of cell is integrated. The structure of mitochondria is normal.
The quantity of neutrophile granulocyte and macrophagocyte are reduced. Pathological semiquantitative analysis show that, MLI has significant difference comparing with model group(P<0.05). MAN has trend of increase. It manifest that Jieyinqiao group can meliorative alveolar diameter obviously, increase the quantity of bronchoalveolus on some degree.
It manifest that Jieyinqiao group have significant difference comparing with model group on pathological changes. Heat-clearing and detoxicating herbs combined with Radix Platycodi have some meliorative effect on inflammatory reaction and structure of lung tissue.The effect is better than Jiegeng group, Yinqiao group.It reveal that Radix Platycodi exerts synergized action through meridian guiding.
Jieganyinqiao group, that is heat-clearing and detoxicating herbs combined with Radix Platycodi, Glycyrrhiza.The light-microscope observation show,the range of pathological changes reduce,the degree relieve.
The infiltration of inflammatory cell decrease obviously.The structure of bronchoalveolus recover mostly. The ultra-microstructure observation show,the change of alveolar typeⅡepithelial cells is not obviously.The structure of cell is integrate. The structure of mitochondria is normal.
The quantity of neutrophile granulocyte and macrophagocyte are reduced. Pathological semiquantitative analysis show that, MLI has trend of decrease comparing with model group. MAN has significant increase comparing with model group(P<0.01) . It manifest that Jieganyinqiao group can increase the quantity of bronchoalveolus obviously,have meliorative effect on lung tissue structure.
The result reveal that Jieganyinqiao group have significant difference comparing with model group on pathological changes. Heat-clearing and detoxicating herbs combined with Jiegeng ,Glycyrrhiza have obviously meliorative effect on inflammatory reaction and structure of lung tissue.It make out that Radix Platycodi combined with Glycyrrhiza exerts synergized action through compatibility meridian guiding.
Compare with normal group,the amount of white blood cell,the content of IL-1β, TNF-α, TGF-βof model group increase significantly(P<0.01,P<0.01,P<0.05,P<0.05).It show that the model of COPD have obviously sign of inflammation.It is consist with pathological results.
Compare with model group, the amount of white blood cell and the content of IL-1βof Jieyinqiao group have significant different(P<0.05,P<0.01), the content of TNF-αhas trend of decrease. It show that Jieyinqiao group can reduce the amount of white blood cell ,the content of IL-1βand TNF-α.The result reveal that meliorative effect of Jieyinqiao group is related with the decrease of white blood cell ,IL-1βand TNF-α.
Compare with model group, the amount of white blood cell,the content of IL-1β, TNF-α, TGF-βof Jieganyinqiao group decrease significantly(P<0.01,P<0.01,P<0.05,P<0.05).It manifest that therapeutic effect of Jieganyinqiao group is related with the decrease of white blood cell ,IL-1β,TNF-αand TGF-β.
Compare with normal group ,the expression of TFF3 mRNA , the content of VIP in model group have trend of decrease .It show that this two kinds of peptide decrease in pathological state.On other therapeutic groups, TFF3、VIP have increasing trend on some degree. Jiegeng group regulate TFF3 better than other groups.It can speculate that Radix Platycodi‘s synergized action of meridian guiding is related with TFF3.TFF3 may be the target of Radix Platycodi.
Jieganyinqiao group regulate VIP better than other groups.It can speculate that Radix Platycodi combined with have synergized action of compatibility meridian guiding ,it is consist with VIP.
Conclusion:
Heat-clearing and detoxicating herbsherbs combined with Radix Platycodi have synergized action through lung meridian guiding.It can strength the effect of heat-clearing and detoxicating herbsherbs.The mechanism is concerned with TFF3、VIP. Radix Platycodi combined with Glycyrrhiza show some synergized action through compatibility meridian guiding.Its mechanism have relation with VIP.
In order to ensure TFF3、VIP are target of Radix Platycodi,we need many different testing methods to confirm it.
第一部分文献综述。
系统综述了COPD的现代研究、中医药治疗概况、桔梗在呼吸系统的应用以及归经、引经理论的研究进展。
目前,COPD发病情况已在全球引起重视。全球许多学者围绕COPD病因学、发病机理、诊断、治疗等从实验和临床方面开展了大量研究工作,取得了一定的研究成果。大量研究显示,中医药通过其多靶点、多环节、多途径的调理作用在COPD的治疗中具有一定的优势。
归经、引经理论是中医药理论体系的重要组成部分,对中医临床用药发挥指导作用。近年来,许多学者尝试用现代理论、技术和方法对归经、引经进行研究,并取得了一定的成果,但仍未有重大突破,尚需结合相关领域的最新研究进展,不断地探索。
第二部分理论探讨。
梳理历代医家对归经、引经理论的认识,对常用引经药的功效及临床应用进行分析,探讨张仲景《伤寒杂病论》中有关归经、引经的学术思想。
中药归经、引经理论起于秦汉,在金元时代基本确立,明清时代渐趋完善。其中张仲景《伤寒杂病论》所创立的六经辨证与脏腑辨证体系为归经理论的形成奠定了基础。
引经药在方剂中能够引导其它药物的药力直达脏腑、经络等病变部位,使药效集中,从而提高疗效。历代医家认为桔梗是手太阴肺经的引经药,可为“诸药舟楫”。
第三部分实验研究。
目的:从病理形态学角度观察清热解毒药中配伍桔梗后对COPD的治疗作用。从炎症细胞、细胞因子角度探讨清热解毒药中配伍桔梗对COPD治疗作用的机理。从肺内生物活性肽肠三叶因子(trefoil factor family3,TFF3)、血管活性肠肽(vasoactive intestinal peptide,VIP)角度探讨引经机制。
方法:用熏香烟加气管注入脂多糖的联合造模方法建立大鼠COPD模型,将大鼠随机分为七组,即假手术组、模型组、桔梗组(桔梗)、桔甘组(桔梗、甘草)、银翘组(银花、连翘等)、桔银翘组(桔梗、银花、连翘等)、桔甘银翘组(桔梗、甘草、银花、连翘等)。假手术组、模型组灌胃生理盐水,各给药组灌胃相应中药,连续28天。取大鼠肺组织分别制作光镜、电镜标本。通过病理切片及半定量病理分析评价各给药组对COPD中的治疗效果。用ABC-ELISA法测定大鼠肺泡灌洗液(BALF)中IL-1β、TNF-α、TGF-β的含量并计数大鼠BALF中白细胞数量。用RT-PCR技术测定肺组织肠三叶因子(TFF3)mRNA表达。用放免法测定肺组织中血管活性肠肽(VIP)的含量。
结果及分析:
(1)模型组光镜下观察结果显示,大鼠肺泡结构破坏,局部肺泡萎陷,肺泡间隔明显增宽,甚至融合,肺泡壁和间质内有大量炎细胞浸润。支气管上皮明显增生,部分上皮脱落,管壁及其周围有明显炎细胞浸润。超微结构观察显示,大鼠肺泡Ⅱ型上皮细胞变性,细胞表面微绒毛减少、断裂甚或脱失,线粒体肿胀,嵴消失,甚至呈空泡样,肺泡腔内巨噬细胞次级溶酶体增多。半定量病理分析显示,肺平均内衬间隔(MLI)、平均肺泡数(MAN)较假手术组有显著性差异(P<0.01)。表明模型组的肺泡直径增大,单位面积上的肺泡数减少,肺泡结构破坏明显。
提示: COPD模型组镜下改变与假手术组相比具有明显差别,肺组织结构严重受损,炎症反应增多。
桔梗组、桔甘组、银翘组对COPD病理改变与模型组相比均无明显统计学差异。提示单味桔梗或单纯清热解毒药对COPD病变改善不明显。
桔银翘组即在清热解毒药中配伍桔梗,光镜下观察显示,病变范围缩小,程度减轻。炎性浸润明显减少,大部分肺泡结构基本恢复。超微结构显示,肺泡上皮细胞变性不明显,细胞结构多完整,线粒体结构正常,中性粒细胞、巨噬细胞等炎症细胞减少。半定量病理分析显示,肺平均内衬间隔(MLI)较模型组有显著差异(P<0.05),平均肺泡数(MAN)虽无统计学差异,但有一定升高趋势。说明桔银翘组能明显改善肺泡直径,在一定程度上增加肺泡数。
提示:桔银翘组与COPD模型组相比病理改变具有明显差异。清热解毒药中配伍桔梗对COPD的炎症反应、肺组织结构改变具有一定的改善作用,优于单味桔梗组和单纯清热解毒药组,说明桔梗在其中发挥了引经增效作用。
桔甘银翘组即在清热解毒药中配伍桔梗、甘草,光镜下观察显示,病变范围缩小,程度减轻。炎性浸润明显减少,大部分肺泡结构基本恢复。超微结构显示,桔甘银翘组肺泡上皮细胞变性不明显,细胞结构多完整,线粒体结构正常,中性粒细胞、巨噬细胞等炎症细胞减少。肺平均内衬间隔(MLI)较模型组有降低趋势,平均肺泡数(MAN)较模型组显著升高(P<0.01)。提示桔甘银翘组能明显增加单位面积上的肺泡数。对COPD病理状态下肺组织结构有一定恢复作用。
提示:桔甘银翘组与COPD模型组相比病理改变具有显著差异。清热解毒药中配伍桔梗、甘草对COPD的炎症反应、肺组织结构改变具有更明显的改善作用,说明桔梗、甘草配伍后发挥了配伍引经增效作用。
(2)模型组与假手术组相比白细胞总数、IL-1β、TNF-α、TGF-β含量升高,具有显著统计学差异(P<0.01,P<0.01,P<0.05,P<0.05),提示COPD病理模型的具有明显的炎症征象,这与上述病理切片结果相一致。
桔银翘组与模型组相比,白细胞总数、IL-1β有显著统计学差异(P<0.05,P<0.01),对TNF-α有一定降低趋势。说明桔银翘组能够在一定程度上减少COPD模型白细胞总数、IL-1β、TNF-α含量。提示桔银翘组改善COPD病理改变,发挥治疗作用可能与降低白细胞总数、IL-1β、TNF-α含量有关。
桔甘银翘组与模型组相比,白细胞总数、IL-1β、TNF-α、TGF-β含量均有降低,具有显著统计学差异(P<0.01,P<0.01,P<0.05,P<0.05)。提示桔甘银翘组能够在一定程度上减少白细胞总数、IL-1β、TNF-α、TGF-β含量,与桔甘银翘组改善COPD病理改变,发挥治疗作用有关。
(3)模型组TFF3基因表达、VIP含量较假手术组均呈降低趋势。表明COPD病理状态下这两种神经肽水平均有降低。各治疗组TFF3、VIP含量与模型组虽无统计学差异,但均有不同程度的上升趋势,其中以桔梗调节TFF3的变化趋势最大,推测桔梗的引经增效作用与调节TFF3有关,TFF3可能为桔梗的作用靶点之一。桔甘银翘组调节VIP变化趋势最大,推测桔梗、甘草的配伍引经效果与调节VIP有关。
结论:
清热解毒药物中配伍桔梗后,表现出一定的肺部引经增效作用,能够使清热解毒药物在肺部的治疗作用增加。这种引经增效作用机制可能与桔梗调节TFF3、VIP有关。配伍桔梗、甘草后表现出一定的配伍引经增效作用,其机制可能与调节VIP关系更为密切。
为进一步确定TFF3、VIP是否为桔梗引经增效作用的靶点,仍需采用多种检测方法从不同角度证实。
Chronic obstructive pulmonary disease (COPD) is a kind of familar respiratory disease, characterized by inflammation in air passage and obstruction of air flow.As a meridian guiding herb in Lung Meridian of Hand-Taiyin, Radix Platycodi is usually used in pulmonary disease.Base on the study of document and theory,we observe the therapeutic effect on COPD and its mechanism when Radix Platycodi as a meridian guiding herb,combined with heat-clearing and detoxicating herbs.Furthermore,we explore the mechanism of meridian guiding effect of Radix Platycodi.The thesis is totally divided into three parts:
The first part is literature review.
Summarize the modern research and therapeusis of Chinese medicine in COPD,the Radix Platycodi’application in respiratory system ,the researching progress in the theory of meridian tropism and guiding.
At present,the incidence of COPD is attached importance by many researchers in the world.Many people do a lot of experimental and clinical study work with COPD about etiology, pathogenesy, diagnosis, therapeusis ect.And these studies acquire many achievements.A great deal of researchs show that chinese medicine have some advantages on the treatment of COPD.Because they have effects on many targets, elements and pathways.
The theory of meridian tropism and guiding is one of the important part in Chinese medicine.It has directive effect on clinic.Recently years,many researchers attempt to study it using mordern theory, technique and methods.These studies obtained a certain progress, but have not grave breakthrough and still need explore it combining the latest researching progresses.
The second part is theoretical study.
Comb the understanding of Chinese doctors about the theory on meridian tropism and guiding in the history of Chinese medicine.Analyse the effect and clicical application of meridian guiding herbs.Explore academic ideology of Zhangzhongjing about the theory of meridian tropism and guiding in Treatise On Cold-Attack and Miscellaneous Disease.
The theory of meridian tropism and guiding was originated from Qin and Han dynasties, established in Jin and Yan dynasties, perfected in Ming and Qing Dynasties.The six meridian syndrome differentiation and visceral syndrome differentiation,which founded by Zhang zhongjing,were the foundation of the theory .
The meridian guiding herbs can lead other medicine to diseased region,concentrate drug action,improve the effect. Radix Platycodi is considered as a meridian guiding herb in Lung Meridian of Hand-Taiyin,possessing the floating effect. It is usually used in pulmonary disease.
The third part is experimental study.
Objective:Obsever the therapeutic effect of heat-clearing and detoxicating herbs compined with Radix Platycodi on COPD through pathomorphology.Explore the mechanism of the therapeutic effect through inflammatory cell and cytokine. Study the mechanism of meridian guiding through TFF3、VIP.
Methods:COPD rat model was induced by cigarette smoking inhalation and intratracheal LPS exposure.Rats were divided into 7 groups,namely normal group,model group, Jiegeng group(Radix Platycodi),Jiegan group(Radix Platycodi, Glycyrrhiza),Yinqiao group(Flos Lonicerae, Forsythia suspense, ect),Jieyinqiao group(Radix Platycodi,Flos Lonicerae, Forsythia suspense,ect),Jieganyinqiao group(Radix Platycodi,Glycyrrhiza,Flos Lonicerae, Forsythia suspense,ect). Normal group and model group were given saline,other groups were given corresponding herbal medicine, continuously for 28 days. Takeing lung tissue of rats, making specimen for optical microscope and electron microscope.
Measures the content of TNF-α,TGF-,IL-1βwith the ABC-ELISA method and count the quantity of white blood cell in BALF. Measures trefoil Factor Family3 (TFF3) mRNA expression on the lung with RT-PCR technique. Measures the content of vasoactive intestinal peptide (VIP) in the lung with radio-immunity methods.
Results and analysis:
The light-microscope observation show that in the model group ,the structure of bronchoalveolus is destructive,detelectasis and the interval is broaden, coalesce. There have many inflammatory cells infiltration in alveolar wall and interalveolar septum. Bronchial epithelium proliferate obviously.Some parts of epithelium are deciduous. Inflammatory cell infiltrate into bronchial wall.
The ultra-microstructure observation show that alveolar typeⅡepithelial cells degenerate, microvilli in the surface of cell deplete, fragmentation and deciduous. Mitochondria swelling, ridge disappearing. secondary lysosome of macrophagocyte increase.
Pathological semiquantitative analysis show that MLI、MAN have significant difference comparing with normal group(P<0.01).It manifest that alveolar diameter increased,the quantity of bronchoalveolus reduced,the structure of bronchoalveolus is detoryed obviously.
The results manifest that the changes in model group have significant difference comparing with normal group in microscope.The structure of lung tissue is distoryed severly,inflammatory reaction increased.
Jiegen group, Jiegan group,Yinqiao group have not obviously different on pathological changes comparing with model group.It manifest that when Radix Platycodi and heat– clearing and detoxicating herbs use separately ,the meliorative effect on pathological changes is not obviously.
Jieyinqiao group ,that is heat-clearing and detoxicating herbs combined with Radix Platycodi.The light-microscope observation show,the range of pathological changes reduce,the degree relieve.
The infiltration of inflammatory cell decrease obviously.The structure of bronchoalveolus recover mostly. The ultra-microstructure observation show,the change of alveolar typeⅡepithelial cells is not obviously.The structure of cell is integrated. The structure of mitochondria is normal.
The quantity of neutrophile granulocyte and macrophagocyte are reduced. Pathological semiquantitative analysis show that, MLI has significant difference comparing with model group(P<0.05). MAN has trend of increase. It manifest that Jieyinqiao group can meliorative alveolar diameter obviously, increase the quantity of bronchoalveolus on some degree.
It manifest that Jieyinqiao group have significant difference comparing with model group on pathological changes. Heat-clearing and detoxicating herbs combined with Radix Platycodi have some meliorative effect on inflammatory reaction and structure of lung tissue.The effect is better than Jiegeng group, Yinqiao group.It reveal that Radix Platycodi exerts synergized action through meridian guiding.
Jieganyinqiao group, that is heat-clearing and detoxicating herbs combined with Radix Platycodi, Glycyrrhiza.The light-microscope observation show,the range of pathological changes reduce,the degree relieve.
The infiltration of inflammatory cell decrease obviously.The structure of bronchoalveolus recover mostly. The ultra-microstructure observation show,the change of alveolar typeⅡepithelial cells is not obviously.The structure of cell is integrate. The structure of mitochondria is normal.
The quantity of neutrophile granulocyte and macrophagocyte are reduced. Pathological semiquantitative analysis show that, MLI has trend of decrease comparing with model group. MAN has significant increase comparing with model group(P<0.01) . It manifest that Jieganyinqiao group can increase the quantity of bronchoalveolus obviously,have meliorative effect on lung tissue structure.
The result reveal that Jieganyinqiao group have significant difference comparing with model group on pathological changes. Heat-clearing and detoxicating herbs combined with Jiegeng ,Glycyrrhiza have obviously meliorative effect on inflammatory reaction and structure of lung tissue.It make out that Radix Platycodi combined with Glycyrrhiza exerts synergized action through compatibility meridian guiding.
Compare with normal group,the amount of white blood cell,the content of IL-1β, TNF-α, TGF-βof model group increase significantly(P<0.01,P<0.01,P<0.05,P<0.05).It show that the model of COPD have obviously sign of inflammation.It is consist with pathological results.
Compare with model group, the amount of white blood cell and the content of IL-1βof Jieyinqiao group have significant different(P<0.05,P<0.01), the content of TNF-αhas trend of decrease. It show that Jieyinqiao group can reduce the amount of white blood cell ,the content of IL-1βand TNF-α.The result reveal that meliorative effect of Jieyinqiao group is related with the decrease of white blood cell ,IL-1βand TNF-α.
Compare with model group, the amount of white blood cell,the content of IL-1β, TNF-α, TGF-βof Jieganyinqiao group decrease significantly(P<0.01,P<0.01,P<0.05,P<0.05).It manifest that therapeutic effect of Jieganyinqiao group is related with the decrease of white blood cell ,IL-1β,TNF-αand TGF-β.
Compare with normal group ,the expression of TFF3 mRNA , the content of VIP in model group have trend of decrease .It show that this two kinds of peptide decrease in pathological state.On other therapeutic groups, TFF3、VIP have increasing trend on some degree. Jiegeng group regulate TFF3 better than other groups.It can speculate that Radix Platycodi‘s synergized action of meridian guiding is related with TFF3.TFF3 may be the target of Radix Platycodi.
Jieganyinqiao group regulate VIP better than other groups.It can speculate that Radix Platycodi combined with have synergized action of compatibility meridian guiding ,it is consist with VIP.
Conclusion:
Heat-clearing and detoxicating herbsherbs combined with Radix Platycodi have synergized action through lung meridian guiding.It can strength the effect of heat-clearing and detoxicating herbsherbs.The mechanism is concerned with TFF3、VIP. Radix Platycodi combined with Glycyrrhiza show some synergized action through compatibility meridian guiding.Its mechanism have relation with VIP.
In order to ensure TFF3、VIP are target of Radix Platycodi,we need many different testing methods to confirm it.
引文
[1] 施焕中.慢性阻塞性肺疾病,人民卫生出版社,北京,2006:1
[2] Pauwels RA, Buist AS,Calverley PM, et al. GlobalStrategy for the diagnosis mana gement and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease [GOLD] Workshop summary[J]. Am J Respir Crit Care Med, 2001, 163(5): 1256-1276
[3] National Heart,Lung,and Blood Institute. Morbidity & mortality:chartbook on cardiova scular, lung,and blood diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1998. Available from:URL:www. nhlbi. nih. gov/ nhlbi/ seiin// other/ cht-book / htm .
[4] 赵鸣武.慢性阻塞性肺疾病认识的进展及问题. 临床内科杂志,2004,21(1):21-22
[5] 董碧蓉.慢性阻塞性肺疾病的诊治进展[J].现代临床医学,2007,33(1) 增刊:13-16
[6] 程显声,武阳本,李景周等.吸烟者慢性阻塞性肺病易患因素的研究[J].中华结核和呼吸杂志,1999,22:602-604
[7] 史清明,张宜文,倪进发.慢性阻塞性肺病危险因素的病例对照研究[J]. 安徽预防医学, 2002,8(4):209-210
[8] MoolgavkarSH.Air pollution and hospital admissions for chronic obstructive pul monary disease in three metropolitan areas in the United States[J]. lnhal Toxico1, 2000,12(Suppl 4):75-90
[9] 张金良,周瑾,谢绍东等. 北京市空气质量与每日居民死亡关系的研究[J]. 环境与健康杂志,2003,20(2):75-78
[10] Peinado VI, Barbera JA, Abate P,Ramirez J, Roca J,Santos, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med 1999, 159: 1605-1611
[11] Finkelstein R,Fraser RS,Ghezzo H,et al. Alveolar inflammation and its relation to emphysema in smokers[J].Am JRespir Crit Care Med,1995,152(5Pt1): 1666-1672
[12] Saetta M ,Di Stefano A, Turato G, et a1. CD8+T-ymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,1998,157(3Pt1):822-826
[13] 张永,程德云,王慧等.慢性阻塞性肺疾病大鼠肺内白细胞介素8和肿瘤坏死因子α与气道炎症的研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359
[14] Keatings VM, Collins PD, Scott DM, et a1.Diferences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma [J].Am J Respir Crit Care Med, 1996,153(2):530-534
[15] Pang G, OrtegaM ,Zighang R,et al. Autocrine modulation of IL-8 production by sputum neutrophils in chronic bronchial sepsis[J]. American Journal of Respiratory and Critical Care Medicne,1997,155(2):726-731
[16] LundbladL K,Thomp son-Figueroa J, Leclair T,et al.Tumor necrosis factor alpha over-expression in lung disease:a single cause behind a complex phenotype[J]. Am J Resp ir Crit CareMed,2005,171:1363-1370
[17] 黄勤欢,张扣兴,薛青.慢性阻塞性肺疾病患者血清中黏附分子、肿瘤坏死因子和白介素-8的变化[J].现代中西医结合杂志,2004,13:3096-3103
[18] Utsugi M,Dobashi K,Kaga Y,etal.Glntathione redox regulates lipopolysac charide induced IL-12 prodnction through P38 mitogen activated protein kinase activation inhuman monocytes: role of glutathione redox in IFN-gamma priming of IL-12 production[J].J Leukoo Biol,2002,71:339-347
[19] Dobashi K,Aihara M,Araki T,et al. Regulation of LPS induced IL-12 production by IFN-gmnma and IL-4 throngh intracellular glutathionestatus in human alveolarmacrophages[J].Clin Exp Immunol,2001,124:290-296
[20] Terence S,Rhian HO,Angshu B,et a1.Respiratory viruses,symptoms,and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,164(9):1618-1623
[21] Roland M,Bhowmik A,Sapsford RJ,et a1.Sputum and plasma endot helia1 levels in exacerbations ofchronic obstructive pulmonary disease[J].Thorax, 2001, 56:30-35
[22] 牟小芬,田亚平,郭广宏等.老年COPD稳定期患者病程发展与细胞因子等因素的关系[J].中国临床康复,2005,9(7):88-90
[23] Charles KIII , Robert J H ,Zhu Z ,et al. Airway Hyperresponsiveness and Airway Obstruction in Transgenic Mice[J].Am J Respir Cell Mol Biol,2000,22 (3):289-295
[24] Gilrnour PS. Rahman L, Hayashi S, et al.Adenoviral EIA Primes alveolar epitbethal cells to PM(10)-induced ranscrip tion of interleukin-8[J].Aml Physical lung cell Mol Physical,2001,281:598-606
[25] 董平,孔令敏,陈文靖等.COPD 急性发作期白介素-8 、肿瘤坏死因子-α的表达与预后分析[J].中国厂矿医学,2002,15(2):99-100
[26] Yamamoto c,Yoneda T,YoshikawaM,et a1. Airway inflammation in COPD assessed by sputum levels of interleukin-8[J]. Chest,1997,112 (2):505-510
[27] Gillissen A,JaworskaM,OrthM,et al. Nacyatelyn,a novel lysinealt of N-acerylcysteine to angrnent cellular antioxichan defence in virro[J]. RespirMed, 1997,91:159-168
[28] 熊彬,邓俊,熊瑛.慢性阻塞性肺疾病患者血清IL-6、IL-8、IL-18的水平及意义.四川医学[J],2005,26(10):1082-1083
[29] Woodruff PG, Koth LL, Yang YH, et al. Adistinctive alveolar macrophage activation state induced by cigarette smoking [J]. Am J Resp ir Crit Care Med, 2005, 172: 1383 -1392
[30] Baraldo S, Bazzan E, Turato G, et al. Decreased exp ression of TGF-beta type II receptor in bronchial glands of smokers with COPD[J]. Thorax, 2005, 60: 998 -1002
[31] 韩玲,,许建英.慢性阻塞性肺疾病患者气道上皮细胞TGF-β1 表达的研究[J],山西医科大学学报,2007,38(1):31-33
[32] Dalai S,Imai K,Mercer B,et a1.A role for collagenase (matrix metallo prote inase-1) in pulmonary emphysema[J].Chest,2000,117:227s-228s
[33] Jeffery PK, Lymphocytes,chronic hronchitis and chronic obstructive primonary disease [J].Novartis Found Symp,2001,234:149-161
[34] 李雯,徐永健,魏华平等.白介素-4和白介素-6在慢性阻塞性肺病肺组织中的表达[J].中国组织化学与细胞化学杂志,2001,10(4):425-428
[35] 彭建萍.细胞因子与慢性阻塞性肺疾病[J].江西医学院学报,2005,45(4):148-149
[36] Taraseviciene-Stewart L, Scerbavicius R,Choe KH,et al. Ananimalmodel of autoimmune emphysema[J].Am J Respir Crit CareMed,2005,171:734-742
[37] Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J]. Am J Respir Crit Care Med, 2001, 163: 1256 – 1276
[38] Lomas DA, Mahadeva R. Alpha 1antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for treatment[J].J Clin Invest,2002,110:1585-1590
[39] Lin S, Roche N, Oliver BG,et al. Balance of matrix metalloprotease-9 and tissue inhib itor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10[J].Am J Respir Crit Care Med.2000,162:1355-1360
[40] Chapman HA Jr ,Shi GP. Protease injury in the development of COPD[J].Thomas A. Neff Lecture.Chest,2000,117:295-299
[41] Lomas DA, Mahadeva R. Alpha 1 antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for treatment[J].J Clin Invest,2002,110:1585-1590
[42] Lin S, Roche N, Oliver BG, et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10[J].Am J Respir Crit Care Med. 2000, 162:1355-1360
[43] Rennard S,Decramer M,Calverley PM,et al Ampact of COPD in North America and Europe in 2000 :subjects perspective of Confronting COPD International Survey[J]. Eur Respir J,2002;20:799-805
[44] Tetley TD.Macrophages and the pathogensis of COPD[J].Chest,2002, 121:156s-159s
[45] Koyama H,Geddes DM.Gene,oxidative stress and the risk of chronic obstru ctive pulmonary disease[J].Thorax,1998,53(Suppl2)10-14
[46] MacNeeW.Oxidants/antioxidants and chronic obstructive disease:pathogenesis to therapy[J].Novatis Found symp.2001,234:169-185
[47] Sauleda J.Garcia-paliner FJ,Gonzalez G,et al. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease,asthma and chronic arthritis[J]. Am J Respir Crit Care Med,2000,161:32-35
[48] Repine JE,Bast A,Lankhorst 1.The oxidative stress Study Group.Oxidative stress in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1997,156: 341-357
[49] 蔡珊 ,陈平 .感染与慢性阻塞性肺疾病 [J].国外医学呼吸系统分册 , 2005, 25(6): 412-413
[50] Prieto A, Reyes E ,Bernstein ED,et a1. Defective natural killer and phagocytic activeties in chronic obstructive pulmonary disease are restored by glycophosphopepica l (Inmunoferon)[J].Am J Respir Crit Care Med, 2001, 163:1578-1583
[51] Hunter MH, King DE. COPD: Management of Acute Exacerbations and Chronic Stab le Disease [J].Am Fam Physician,2001,64:603-612
[52] Miravitlles M,Espinosa C,Fernandez-Laso E,et a1.Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD[J].Chest,1999,116:40-46
[53] Eller J,Ede A,Schaberg T,et a1.Infective exacerbations of chronic bronchitis,Relation between bacterial etiology and lung function [J].Chest,1998,113:1542-1548
[54] Ianni, Majore S, Arzani D, et al.CCR2 and CCR5 gene polymorphism in children with recurrent respiratory infections[J].RespirMed,2001,95(5):130-132
[55] Seemungal TA,Harper-Owen R,Bhowmik A,et a1Respiratory viruses,symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,164: 1618-1623
[56] Pietila MP, Thomas CF. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease[J].Semin Respir Infect,2003,18: 9-16
[57] Takabatake N ,Nakamura H ,Abe S ,et al . Circulating leptin in patients with chronic obstructive pulmonary disease[J].Am JRespir Crit Care Med, 1999,159 (4 Pt 1):1215-1219
[58] Yasuda N, Gotoh K, Minatoguchi S, et al. An increase of soluble Fas, aninhibitor of apoptosis, associated with progression of COPD[J]. Respir Med,1998, 92(8):993-999
[59] Shore S,Kobzik L ,Long NC. Increased airway responsiveness to inhaled methacholine in a rat model of chronic bronchitis[J].AmJ Respir Crit Care Med. 1995, 151: 1931 – 1938
[60] 许建英,杜永成,赵鸣武等.大鼠慢性阻塞性肺疾病模型的建立[J].中国病理生理杂志,2000,16:383-384
[61] 许三林,吴人亮,陈春莲等.E-cadherin在吸烟小鼠气道上皮损伤修复中表达的研究[J].中华结核和呼吸杂志,1999,22:417-419
[62] 赵玉霞,于润江. 吸烟对脂质过氧化系统及a1-抗胰蛋白酶的影响[J].中华结核和呼吸杂志,1998 ,21 :218-219
[63] Marino G.Vitamin C helps cigarette-smoking hamster[J]. Science News, 1994, 146 :86-86
[64] 迟春花. 烟草雾吸入导致COPD 机制的实验研究——大鼠Clara 细胞结构及其分泌蛋白的变化[J].心肺血管病杂志,2000,(3):224-227
[65] 黄念秋,吴善.现代老年呼吸病学[M].北京:人民军医出版社,1998:98
[66] Black Wood RA,Moret L,et al.Emphysema induced by intravenously adminis tered endotoxin in an alphal-antitrypsin-deficient rat model[J]. Am Rev Respir Dis, 1984, 130:231-236.
[67] Stolk J , Rudolphus A ,Davies P ,et al. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysa ccha ride in the hamster[J].JPathol,1992,167:349-356
[68] 许浒,熊密,黄庆华等.细菌感染导致慢性阻塞性肺疾病[J].中华结核和呼吸杂志, 1999,22:739-742
[69] Tavares JL ,Wangoo A ,Dilworth P ,et al Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages[J].Respir Med, 1997, 91:31-39
[70] Li D ,Godfky R ,Rogers AV ,et al .Endotoxin-induced airway intro-epithelial neutrophilia. Goblet cell hyperplasia and metaplasia in the rat :a light and electron microscopic study[J].Eur Respir J,1996,9:424
[71] 马楠,崔德健,梁延杰等. 气道内注入脂多糖法建立大鼠慢性支气管炎模型[J].中华结核和呼吸杂志,1999,22:371-372
[72] Stockly RA. Protease/ Antiprotease : Pathogenesis and role in therapy[J] . Clinical Pulmonary Medicine ,1998 ,5:203-210
[73] 张旭晨,阮英茆,徐新林等. 应用弹性蛋白酶复制金黄地鼠肺气肿模型[J].天津医药, 1999,27:536-537
[74] 张宏,孟亚娟,斯琴等. 烟雾吸入对地鼠弹性蛋白酶性肺气肿的影响[J].实验动物科学与管理,1999,16(4):1-5
[75] 曾勉,郭禹标,谢灿茂等. 猪胰弹性蛋白酶肺气肿模型复制的实验研究[J].现代康复, 2001,5(3):59-60
[76] Hoedal JR,Niewoehner DE.Cigarette smoke inhalation potentiates elastase induced emphysema in hamsters[J]. Am Rev RespirDis,1983,127:478-481
[77] Juanita HJ,Vernooy, Mieke A,et al. Long-Term Intratracheal Lipopolysacc haride Exposure in Mice Results in Chronic Lung Inflammation and Per sistent Pathology[J].Am J Respir.Cell Mol.Biol,2002,1:1592-1596
[78] Jan S, Arjan R ,Philip D.Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster[J].Journal of pathology,1992,167:349-356
[79] Hoedal JR ,Niewoehner DE. Cigraette smoke inhalation potentiates elastase-induced emphysema in hasnters[J]. Am Rev Respir Dis, 1983, 127: 478-481
[80] 宋一平,崔德健,茅培英,等. 慢性阻塞性肺病大鼠模型的建立及药物干预的影响[J].中华内科杂志,2000,39:556
[1] 单丽囡,刘小虹,李兰铮等. 从痰瘀论治慢性阻塞性肺疾病体会[J].湖南中医杂志, 2005,21(2):92
[2] 张文江 ,苗青 ,张燕萍等 .许建中学术思想经验传承研究 [J].中华中医药杂志,2007,22(12):854-856
[3] 傅曙华. 慢性阻塞性肺疾病病因病机及治法探讨[J]. 湖南中医杂志, 2003,19(4): 3-4
[4] 史锁芳, 曹世宏,徐丽华等.清源化痰颗粒治疗慢性阻塞性肺病发作期的临床研究[J].南京中医药大学学报,2000,16(3):8l-82
[5] 黄礼明. 试论痰、瘀、虚在慢性阻塞性肺病辨治中的重要性[J].贵阳中医学院院报,2000,22(1):5-7
[6] 董滟. 中医治疗 COPD 稳定期的优势评析[J].中医药学刊,2004,22(1):155
[7] 万文蓉. 论阳虚痰瘀是慢性阻塞性肺疾病的基本病机[J]. 中医药学刊, 2005,23(9): 1672
[8] 曹红九,王东华.益气活血法治疗慢性阻塞性肺病[J].湖北中医杂志,2001,23(1):27
[9] 张弛,林如平,刘洪等.鱼腥草注射液对慢性阻塞性肺疾病患者炎症细胞因子与肺功能的影响[J].中国中医药科技,2006,13(5):294-296
[10] 许建中.慢性阻塞性肺疾病中医诊治探讨[J].江苏中医药,2006,27(7):4-5
[11] 刘文萍,丁海菊.中西医结合治疗慢性阻塞性肺疾病急性期疗效观察[J].中国医院用药评价与分析,2007,7(1):58-59
[12] 李康 ,张晓云 .中西医结合治疗慢性阻塞性肺疾病急性加重期 28 例 [J].中医杂志,2007,48(3):242-243
[13] 陈 利 平 . 中西医结合治疗慢性阻塞性肺疾病急性发作期 60 例 [J]. 河南中医2006,26(1):64-65
[14] 荆小莉,王东平,李欣等.清肺化痰祛瘀方治疗慢性阻塞性肺疾病急性加重期的研究[J].中国中西医结合急救杂志,2006,13(5):270-272
[15] 陈斯宁,黄美杏,古立新等.清肺化痰颗粒治疗慢性阻塞性肺疾病急性加重期痰热郁肺证临床观察[J].广西中医药,2007,30(1):8-10
[16] 李小春,罗建辉,王金凤.痰热清注射液治疗慢性阻塞性肺疾病急性发作疗效观察[J].中国中医急症,2006,15(7):695-697
[17] 朱 频 , 郦 永 平 . 慢 性 阻 塞 性 肺 病 急 性 加 重 期 中 医 证 治 规 律 探 讨 [J]. 河 南 中 医 , 1998,18(6):369
[18] 张元兵,洪广祥.“肺与大肠相表里”理论在慢性阻塞性肺疾病急性发作期的应用[J].江西中医药,2000,31(3):15-16
[19] 林嬿钊，韩云，李芳.通下法配合无创通气治疗慢性阻塞性肺疾病急性加重期呼吸衰竭 15 例[J].新中医,2005,37(1):41-42
[20] 王学东.慢性阻塞性肺疾病中医治疗[M].江苏科学技术出版社.2002:102
[21] 方堃, 石占利, 李志会. 通腑平喘汤联合机械通气治疗慢性阻塞性肺疾病并发呼吸衰竭的临床疗效观察[J].中国中西医结合急救杂志,2006 ,13(5):291-293
[22] 沈晓强,鲍志坚,胡旭等.冬虫夏草治疗肺肾两虚证慢性阻塞性肺疾病[J].浙江中西医结合杂志,2005,15(2):84-85
[23] 王莒生,苑惠清,刘薇.参灵胶囊治疗慢性阻塞性肺部疾病缓解期的临床研究[J].北京中医,2006 ,25 (9):518-520
[24] 雷明盛,唐淑明,谭芳.参芪肺宝治疗慢性阻塞性肺疾病稳定期 30 例临床观察[J].江西中医药,2006, 37(8):43
[25] 孙志佳.温补肺肾法治疗慢性阻塞性肺疾病的理论与临床探讨[J].中医药管理杂志,2006 ,14(5):56-58
[26] 张贻雯,刘刚.益气补肾汤提高慢性阻塞性肺疾病患者体液免疫的研究[J].实用中西医结合临床,2006,6(5):19-20
[27] 王胜,张念志,季红燕等. 益肺健脾中药对慢性阻塞性肺疾病气道炎症作用的研究[J].中国中西医结合杂志,2002,22(6)462
[28] 刘小虹 ,刘琼 .培土生金法在慢性阻塞性肺疾病缓解期的应用研究 [J].新中医 , 2002,34(10):18-19
[29] 王胜,季红燕,张念志等.益肺健脾中药改善慢性阻塞性肺疾病患者肺功能及营养状况[J].中国临床康复,2005,9(31):141-143
[30] 司东波.调理脾胃法对慢性阻塞性肺疾病预后的影响 [J].中国中医急症 ,2005,15 (8):838-839
[31] 殷四祥,汪陆庆,王章桂.生脉注射液对慢阻肺发作期肺功能及血气分析的影响[J].中医药临床杂志,2006,18(6):557-558
[32] 崔焱,梁直英,董竞成.活血化瘀方治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中国中西医结合杂志,2005,25(4):327
[33] 吴惕虎.慢性阻塞性肺病以瘀血论治的临床观察[J].河北中医,1997,19(3):17
[34] 林育华.活血化瘀法治疗慢阻肺 95 例临床观察[J].新中医,1998,30(2):33
[35] 黄美虹,韩云.川芎嗪注射液对慢性阻塞性肺疾病急性加重期主要结局指标的影响[J].现代中西医结合杂志,2004,13(15):2002-2003
[36] 张立山,武维屏,董安铭等.肺康方治疗慢性阻塞性肺疾病肺动脉高压的临床研究[J].北京中医药大学学报, 2003,36(3):70-73
[37] 曾飞球,刘建新,林夏飞.经络导平佐治慢性阻塞性肺疾病的临床研究[J].中国老年学杂志,2004,7(24):605
[38] 陈钦 ,谢田钢 ,金先桥 . 推拿治疗慢性阻塞性肺疾病的疗效 [J].中国临床康复,2006,10(7):10
[39] 孙树起, 郭丕春. 耳针埋穴法治疗 COPD 并少量咯血临床观察[J].中华实用中西医杂志,2004,4(17):16
[40] 潘小峰,高祥福.红花汤雾化吸入对慢性阻塞性肺病缓解 30 例观察[J]. 江中医杂志 ,2000,35(50):216
[41] 赵湘,陈铭华,胡雪梅等.气道阻塞性疾病雾化吸入疗法进展[J].实用中西医结合杂志,1997,16(3):293
[42] 王玉光,许世芳.清开灵注射液支气管肺泡灌洗治疗慢性阻塞性肺病 30 例[J].山东中医杂志,2000,19(5):274-275
[43] 王雪琴,岳留枝.中西医结合康复治疗仪治疗慢支肺气肿 64 例临床分析[J].河南医药信息,1997,5(8):46-47
[44] 郑彩霞,王洪刚,刘振安.穴位贴敷为主治疗慢性阻塞性肺疾病 90 例[J].中医研究,2005,18(10):36-37
[45] 庞巧玲,鲍正宏.穴位注射和中药贴敷防治慢性阻塞性肺疾病 180 例[J].中国民间疗法,2005,13(2):31
[46] 季红燕,张念志,陈炜等.参七虫草胶囊对慢性阻塞性肺疾病大鼠模型细胞因子的影响[J].安徽医科大学学报,2003,38(2):272-274.
[47] 连金诗.黄芪注射液对 COPD 患者 T 细胞亚群影响的临床观察[J]. 黑龙江中医药杂志, 2002,5:9-10
[48] 钟冬梅.生脉注射液改善慢性阻塞性肺病患者免疫功能的疗效观察[J].华西药学杂志,2002,17(4):315
[49] 李素云,李健生,马利军等.益气养阴活血化瘀法对慢性阻塞性肺疾病稳定期免疫功能的影响[J].河北中医,2001,23(12):899
[50] 田正鉴,邹新蓉.慢性阻塞性肺疾病扶正固本价值评述[J].中医药学刊, 2001, 19: 236
[51] 毛兵,李廷谦,迟焕海等.玉屏风散颗粒治疗慢性阻塞性肺病的临床研究[J].成都中医药大学学报,1999,22(2):16-19
[52] 张念志,赵丽萍,卓秀珍等. 参七虫草胶囊治疗慢性阻塞性肺疾病的大鼠模型肿瘤坏死因子-amRNA 基因表达的影响[J].中国中医急症,2004,(13)2:107-108.
[53] 张颖,李廷谦,王刚等. 痰热清注射液治疗慢性阻塞性肺疾病急性加重期(痰热阻肺证)的随机对照试验[J].中国循证医学杂志,2004,4(5):300
[54] 李素云,程先宽,李建生等.通塞颗粒对老年 COPD 急性加重期炎性细胞因子的影响[J].辽宁中医杂志,2003,30(8):624-625
[55] 耿晓照,雷明盛.嗽宝合剂对 COPD“肺气虚证”大鼠血清 TNF-α 及 IL-8 含量变化影响[J].贵州医药,2005,29(9):782-785
[56] 张朝宁,吴立文,孙杰等. 益肾通肺汤对 COPD 大鼠血清 IL-8、TNF-α 的影响[J].甘肃中医学院学报,2006,23(1):23-25
[57] 王文生,雷明盛,张敏.参芪肺宝对 COPD“肺气虚证”大鼠血清 TNF-α 及 IL-8 含量变化的影响[J].江西中医学院学报,2007,19(1):72
[58] 张伟,李刚,张心月.小青龙汤对慢性阻塞性肺疾病大鼠核因子 κB 和 γ-谷氨酰半胱氨酸合酶表达的干预作用[J].浙江中医药大学学报,2006,30(5):457-460
[59] 谢强敏,方理本,张洪泉.哮喘和 COPD 的新概念及新药[M] .北京:科学出版社,2003:52-71
[60] 王凤仪,李生财,李立等. 敦煌古方“紫苏煎”对慢性支气管炎大鼠血清、肺组织中SOD、MDA、NO 含量的影响[J].甘肃中医学院学报,2003,20(2):14-17
[61] 杨牧祥,方朝义,谷振勇等.咳喘宁胶囊对慢性支气管炎大鼠血清、肺组织及支气管肺泡灌洗液 SOD、CAT 活性及 MDA 含量的影响[J].中国中医基础医学杂志,2002,8 (1):14-18
[62] 李原青,李亚光.加减补肺汤抗氧化治疗慢性阻塞性肺疾病的实验研究[J] .江西中医学院学报,2004,16(4):61-62
[63] 张葡萄,陈真如.复方丹参注射液对慢性肺心病患者血中脂质过氧化物及抗氧化物酶活性的影响[J].中国中西医结合杂志,1994,14 (8):474-477
[64] 朱渊红,应可净,蔡宛如,等.黄芪注射液对慢性阻塞性肺疾病急性加重期氧化/抗氧化失衡的影响[J],中国中医急症,2004,13(9):597
[65] 赵长鹰,洗英森,孟辉等. 金水六君煎对慢性支气管炎小鼠血清超氧化物歧化酶活力和丙二醛含量的影响[J].中国中西医结合杂志,2001,21(11):843-844
[66] 马利军,吴纪珍,牛红丽等. 老年 COPD 患者急性发作期与缓解期细胞因子及 SOD、MDA 变化[J].中国老年学杂志,2003,23(3):191-192.
[67] 张伟,邵雨萌,张心月.人参蛤蚧散对慢阻肺模型大鼠核因子 κB 和 γ-GCS 表达的干预作用[J].山东中医药大学学报,2006,30(5):399-401
[68] 刘力, 唐岚, 徐德生等.生地注射液对脂多糖诱导大鼠肺部炎症的影响[J].中国中药杂志,2007,32(6):526-528
[69] 曾征,刘雨星.穴位敷贴对实验性慢性支气管炎的血液流变学影响[J].中医外治杂志,1999,8(3):5-6
[70] 张伟,周兆山,贾新华. 养血益气法对慢性支气管炎大鼠血液流变学的影响[J].中国中医药科技,2002,9(2):951
[71] 郑洁.“治肺不远温”在慢性阻塞性肺疾病(COPD)急性发作期的临床研究[J] .江西中医药,2000,3(6):20-22
[72] 赵湘,陈明华,胡梅雪等. 雾化吸入“复方三拗液”治疗慢性阻塞性肺疾病的临床研究[J].中西医结合实用临床急救 1998,5(6)∶241-44
[73] 江淳涓,毕小利,王跃. 生地注射液对慢性阻塞性肺疾病患者血液流变学及肺功能的影响[J].实用中医药杂志,2002,18(8):7-8
[74] 吴景硕,张琳.络泰对慢性阻塞性肺疾病患者血液流变学及血气分析的影响[J].中草药,2002,33(9):832-833
[75] 林春龙,张珍祥,徐永健.川芎嗪和尼群地平配伍治疗慢性阻塞性肺病的机制探讨[J].中国中西医结合杂志,2001,21(1):28-30
[76] 雷明盛,唐淑明,张敏.参芪肺宝合剂对 COPD“肺气虚证”大鼠的作用及对血浆 ET的影响[J],江西中医学院学报,2006,18(4):79-80
[77] 汤泰秦,刘晓妍,侯励.肺压宁胶囊治疗慢性阻塞性肺病 73 例疗效观察[J].暨南大学学报(医学版),2002,23(12):42
[78] 林春龙,张珍祥,徐永健等. 川芎嗪与尼群地平配伍对慢性阻塞性肺病患者血流动力学的影响[J].中国中西医结合杂志,2001,21(3):183-185.
[1] Han SB ,Park SH ,Lee KH , et al.Polysacchar deslated from the radix of plat ycodon grandiflorum selectively actvates B cells and macrop hages but not T cells[J].Immunol,2001,1(11):1969
[2] Choi CY, Kim J Y , Kim YS , et al.Augmentation of macrophage functions by an aqueous extract isolated from Platycodon grandiflorum[J].Cancer Lett , 2001, 166(1):17
[3] Choi CY , Kim J Y, Kim YS ,et al .Aqueous extract isolated from platycodon grandiflorum elicits the release of nitricoxide and tumor necrosis factor-alp ha frommurine macrophages[J].Int Immunopharmacol, 2001, 1(6):1141
[4] Wang C,Levis GBS ,Lee EB ,et al .Platycodin D and D3 isolated from the root of platycodon grandiflorum modulate the production of nitricoxide and secretion of TNF-alpha in activated RAW 264.7 cells[J].Int Immnopharmacol, 2004,4(8):1039.
[5] Yoon YD ,Han SB , Kang J S , et al .Toll-like receptor 4 - dependent activation of macrophages by polysaccharideisolated from the radix of Platycodon grandilo rum[J].Int Immunopharmacol,2003,3(13～14):1873
[6] Ahn ks,Noh E J,Zhao H L,et al.Inhibition of inducible nitricoxide synthase and cycloxygenase Ⅱ by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells[J].Life Sciences, 2005, 76(20): 2315
[7] Lee JH. Choi YH,Kang HS,et al.An aquecous extract of Platycodiradix inhibits LPS-induced NF-kappaB nuclear translocation in human cultured airway epithelial cells[J].Int J Mol Med,2004,13(6):843
[8] Kim YP, Lee EB,Kim SY,et al.Inhibition of prostag landin E2 production by platycodin D isolated from the root of platycodon grandiflorum[J].Planta Med,2001,67(4):362
[9] 高学敏.中医药学高级丛书——中药学[M].北京:人民卫生出版社,2000:1217
[10] 王本祥.现代中药药理学[M].天津:天津科学技术出版社,1997:949
[11] Shin C Y,Lee WJ,Lee EB,et a1Platycodin D and D3 increase airway mucin releae in vivo and in vitro in rats and hamstersf [J].PIanta Med,2002,68(3):221
[12] Lee KI,Jeong HG.Protective efect of Platycodi radix on carbon tetr achlo ride — induced hepatotoxicity[J].Food Chem Toxicol,2002,40(4):5l7
[13] Lee KJ,Kim JYJung KS,et a1Suppressive efects of Platycodon gran dif lor um on the progress of carbon tetrachloride—induced hepatic fibrosis[J].Arch Pharm Res,2004,27(12):1238
[14] Lee KJ,Choi CY,Chung YC,et a1.Protective efect of saponins derived from roots of Platycodon grandiflorum on tert—butyl hydroperoxide—induced oxidative hepatotoxicity[J].Toxicol Lett.2004,147(3):271
[15] Lee KJ,You HJ,Park SJ,et a1.Hepatoprotective efleets of PIatyc—edon grandiflomm on acetaminophen -induced liver damage in mice [J].Cancer Lett,2001,174(1):73
[16] Kim K ,Seo E ,Lee Y , et al .Effectof dietary platycodon randiflorum on the improvement of insulin resistance in obese Zucker rats[J].J Nutr Biochem, 2000,11(9):420
[17] 高云芳,陈超,张海祥等.桔梗总皂苷对大鼠高脂血症的影响[J].中草药, 2000, 31 (10):764
[18] Lee JY,Yoon JW, Kim CT et a1.Antioxidant activity of phenylpropanoid esters isolated and identified from Platycedon grandiflorum A DC[J]. Phytochem istry,2004,65(22):3033
[19] 东野长新,东野广刚.化痰平喘合剂治疗慢性阻塞性肺疾病 30 例[J].河北中医,2004,26(9):672
[20] 赵菁华,杨广源,白燕中西医结合治疗慢性阻塞性肺疾病急性发作 42 例临床观察[J],内蒙古中医药,2007,10:19-20
[21] 陈亚华,陈淑芬,王梅,桔梗射干煎液治疗小儿急性扁桃体腺炎 106 例临床观察[J],黑龙江医药,1999,22(2):43
[22] 金峰.桔梗止咳汤治疗急性气管-支气管炎疗效观察[J].中医研究,1997,10(2):41
[23] 梁燕.克咳胶囊治疗急性气管-支气管炎的临床观察[J].贵阳中医学院学报,1997, 19 (3):32
[24] 杨传英 .车前桔梗汤治疗慢性支气管炎 96 例疗效观察 [J].中国中医药信息杂志,2001,8(3):66-67
[25] 曹红洲. 固本止咳汤治疗慢性支气管炎 45 例[J].河南中医,2000,20(4):45
[26] 朱东碧.中西医结合治疗慢性支气管炎急性发作[J].浙江中西医结合杂志, 2000, 10 (1):32
[27] 瞿结宗.降气平喘汤治疗支气管哮喘 98 例[J].陕西中医,2000,21(10):450
[28] 朱永忠.加减阳和汤治疗寒性哮喘 30 例[J].陕西中医,2000,21(10):49
[29] 沈志忠.自拟二百桔梗白芨汤治疗支气管扩张 32 例[J]. 四川中医,1995,13(8): 39
[30] 闫燕.经方治疗小儿急性病毒性肺炎 101 例[J].国医论坛,2000,15(1):12
[31] 李新成.中西医结合治疗支原体肺炎 48 例[J].湖北中医杂志, 2000,22(4):19
[32] 杨修策.桔梗汤加味治疗肺脓肿一得[J].光明中医,2000,15(4):30-31
[33] 李良辉.中西医结合治小儿肺脓疡临床观察[J].江西中医药,2000,31(2):44
[34] 赵玉洁中西医结合治疗肺脓肿疗效分析[J].贵阳中医学院学报,1997, 19 (2):13-14
[35] 张绍文.达肺冲剂治疗肺结核临床疗效观察[J].中医药学报,2000,(3):18-19
[36] 蓝世隆.抗痨丸治疗结核病 124 例疗效观察[J].新中医,1999,31(1):32-33
[37] 赵孟碧.百合固金汤治疗肺结核 48 例[J].实用中医内科杂志,2002,16(3):141
[38] 曹利平,闻新丽.中西医结合治疗肺心病急性加重期 132 例[J].陕西中医,2002,23 (4):291-292
[39] 陈全寿.肺心汤治疗肺心病 80 例[J].实用中医内科杂志,1998,12(1):38
[40] 邱飞,张玉萍.肺间质纤维化的中医治疗[J],新疆中医药,2003,21(2):25-26
[41] 徐淑江.分期辨证治疗煤工尘肺[J].黑龙江中医药,2000,(2):30
[42] 田立岩,杨春霞,段军.中药桔梗治疗矽肺临床疗效观察[J].中国职业医学,2007,34(4):307
[43] 山广志.电化疗合加味桔梗汤治疗肺癌 50 例[J].中国中西医结合杂志,1999,19(5) : 312
[44] 刘兴国.桔梗散合漱口液治疗慢性咽炎 56 例[J].医药论坛杂志,2005,26(12):57
[45] 邓森田.桔梗甘草汤治疗急慢性咽喉炎 48 例[J].陕西中医,1998(19):5
[46] 孙建平.桔梗汤加味治疗咽炎 193 例[J].光明中医,2002,17(4):46-47
[47] 胡炜.双花桔梗茶治疗慢性咽炎 157 例体会[J].浙江中西医结合杂志, 2002,12(6):370
[1] 施怀生.试论中药归经理论及其与体内代谢过程的关系[J]. 山西中医,1996,12 (6): 32-34
[2] 陆光伟.中药归经及其成分在体内的分布[J].中成药研究,1984,(5):38-39
[3] 郭顺根,牛建昭,贲长恩等.3H-川芎嗪在动物体内分布的放射自显影研究[J].中国医药学报,1989,4(3):17-21
[4] 郭顺根,贲长恩,牛建昭等.3H-川芎嗪在动物体内分布与排泄的定量研究[J].中国医药学报,1989,4(4):22-25
[5] 郭顺根,牛建昭,贲长恩等.3H-白首乌总甙在动物体分布的放射自显影研究[J].中国医药学报,1989,4(5):17-20
[6] 牛建昭,郭顺根,贲长恩等.3H-白首乌总甙在动物体内分布与排泄的定量研究[J].中国医药学报,1989,4(6):30-32
[7] 郭顺根,贲长恩,赵丽云等.3H-栀子总甙整体放射自显影及图像分析与栀子归经的关系[J].北京中医药大学学报,1996,19(4):28-31
[8] 郭顺根,贲长恩,杨美娟等.3H-淫羊藿甙定量分析与淫羊藿归经的关系[J].北京中医药大学学报,1997,20(1):40-43
[9] 徐莲英,戴荣兴,陶建杰等.3H-麝香酮阴道给药途径的探讨[J].中成药研究,1985, (3):5
[10] 沈海葆,叶定江.从中草药化学成分看归经的意义[J].辽宁中医杂志,1985, (3):39-41
[11] 莫启忠,官斌,钱序平等.3H-冰片动力学的研究[J].中成药研究,1982,(8):5-7
[12] 柴立.从微量元素及其配位化合物对组织器官的富集、亲合探讨“归经”的实质[J]. 微量元素,1984,(试刊号):24
[13] 朱梅年,柴立.试论中医“肾”的物质基础——有关微量元素锌、锰的探讨[J].中医杂志,1983,(5):66-68
[14] 徐经采,朱梅年.明目中药的归经与微量元素的关系[J].1987,(2):32-34
[15] 龚跃新,张根海.中药归经理论与微量元素的关系探讨[J].中医药研究,1990, (5):23-25
[16] 王树荣,孙冰,丁国明.中药归经的实验研究[J].中国中药杂志,1994,19(8): 500-502
[17] 孙冰.中药归经研究[J].山东中医学院学报,1994,18(1):2-6
[18] 王树荣,翟继伟,盖英臣等.天麻、桔梗、元胡归经的实验研究[J].上海中医药杂志,1995,(1):44
[19] 李 仪 奎 , 徐 莲 英 , 马 建 平 . 中 药 药 理 和 归 经 关 系 的 统 计 分 析 [J]. 中 药 通 报 ,1998, 13(7):48-50
[20] 高其铭.当归的药理研究与其归经功效关系的探讨[J].中成药研究,1985, (5) :32-34
[21] 徐建民.传统中药甘草的作用机理[J].浙江中西结合杂志,1994,8(增刊):53
[22] 彭成,雷载权.人参皂甙健脾益气作用的实验研究[J].中药药理与临床,1997,13(5): 17-19
[23] 唐学游.试论药物归经的几个问题[J].中医药研究,1992,(2):53-54
[24] 丁荣施.略论中药归经和受体学说[J].广东医学,1986,7(5):28-30
[25] 王海东.归经研究与受体学说的思考[J].湖北中医学院学报,2001,3(3):8-9
[26] 史正新.中药归经与受体学说[J].陕西中医学院学报,1993,16(2):4-5
[27] 贲长恩,郭顺根.中药归经理论研究述评[J].北京中医药大学学报,1999,22(2):2-7
[28] 王世成.从中药归经到导向药物[J].实用中西医结合杂志,1992,5(2):70
[29] 王岚,李东晓.论中药归经引经及其研究方法[J].江西中医学院学报,2002,14 (1):25-27
[30] 伍倩.引经药对 P-糖蛋白的影响[J].现代预防医学,2005,32(7):855-856
[31] 袁昌锦,黄在玲.略论中药归经、引经理论与现代药理受体、载体的关系[J].湖北民族学院学报·医学版,2000,17(1):30-32
[1] 高学敏.新世纪全国高等中医药院校规划教材·中药学[M]. 北京:中国中医药出版社,2002:28
[2] 郭蔼春.黄帝内经素问校注[M]. 北京:人民卫生出版社,1992:1128,331,76,157
[3] 神农本草经辑注[M]. 北京:人民卫生出版社,1995:338,250,108,84,167,48,61
[4] 梁·陶弘景.名医别录[M]. 北京:人民卫生出版社,1986:95,201,199,311
[5] 宋·苏轼,沈括.苏沈良方[M]. 北京:人民卫生出版社,1956::16
[6] 唐·孟诜.食疗本草[M]. 北京:人民卫生出版社,1984:124
[7] 宋·寇宗奭.本草衍义[M]. 北京:人民卫生出版社,1994:134,38,86,91,46
[8] 宋·苏颂.本草图经[M]. 合肥:安徽科学技术出版社,1994:177
[9] 太平惠民和剂局方[M]. 北京:人民卫生出版社,1985:31,46,249,302,308, 38,161
[10] 刘完素医学全书·素问病机气宜保命集[M]. 北京:中国中医药出版社,2006:169
[11] 张元素医学全书[M]. 北京:中国中医药出版社,2006:49,50,
[12] 元·王好古.汤液本草[M]. 北京:人民卫生出版社,1956:11
[13] 明·刘文泰.本草品汇精要[M]. 北京:人民卫生出版社,1982:227,228,229
[14] 明·李时珍.本草纲目[M]. 北京:人民卫生出版社,2004:84,543,1009,982,732,9
[15] 汪昂医学全书·本草备要[M]. 北京:中国中医药出版社,2005:319
[16] 徐大椿医书全集·医学源流论[M]. 北京:人民卫生出版社,1988:165
[1] 尤在泾医学全书·医学读书记[M]. 北京:中国中医药出版社,1999:346
[2] 张元素医学全书·珍珠囊[M]. 北京:中国中医药出版社,2006:72,50,71
[3] 元·王好古.汤液本草[M]. 北京:人民卫生出版社,1956:11,51,29,87,24
[4] 明·陈嘉谟.本草蒙筌[M]. 北京:人民卫生出版社,1988:20
[5] 中国本草全书·第 88 卷·本草洞诠[M]. 北京:华夏出版社,1999:537
[6] 神农本草经辑注[M]. 北京:人民卫生出版社,1995:118
[7] 梁·陶弘景.名医别录[M]. 北京:人民卫生出版社,1986:36,208
[8] 宋·寇宗奭.本草衍义[M]. 北京:人民卫生出版社,1994:46,115
[9] 李时珍.本草纲目[M]. 北京:人民卫生出版社,2004:267,268,92,122
[10] 清·傅青主.傅青主女科[M]. 北京:人民卫生出版社,2006:4
[11] 元·李东垣.珍珠囊补遗药性赋[M]. 上海:上海科学技术出版社,1986:24
[12] 丹溪医集·丹溪心法[M]. 北京:人民卫生出版社,2006:262
[13] 高晓山.中药药性论[M]. 北京:人民卫生出版社,1992:225
[14] 黄宫绣·本草求真[M]. 北京:人民卫生出版社,1987:71
[15] 张璐·本经逢原[M]. 上海:上海科学技术出版社,1959:78
[16] 袁昌锦,黄在玲.略论中药归经、引经理论与现代药理受体、载体的关系[J].湖北民族学院学报·医学版,2000,17(1):30-32
[1] 刘渡舟.分析《伤寒论》几种“载药上浮”的方法[J].陕西中医,1981,2(6):1-2
[2] 宋传荣.浅析《金匮要略》对酒的应用[J].黑龙江中医药,1990,6:49-50
[3] 郝建新.仲景方“药引”初探[J].浙江中医学院学报,1988,12(6):11-12
[4] 陈宝明.刘渡舟教授临证粹要[J].山西中医,1989,5(6):15-17
[1] 李红梅,崔德健,佟欣.熏香烟加气管注内毒素和单纯熏香烟法建立大鼠 COPD 模型[J].中国病理生理杂志, 2002,18(7):808-812
[2] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261
[3] Stolk J , Rudolphus A ,Daviest P ,et al. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster[J].J Pathol,1992,167:349-356
[1] Bazan JF, Timans JC, Kastelein RA, et al. A newly defined interleukin-1 [J]. Nature,1996,379(6566):591
[2] Lappalainen U,Whitsett JA,Wert SE,etal. Interleukin-1 beta causes pulmonary inflammation,emphysema,and airway remodelingin the adult murine lung[J]. Am J Respir Cell Mol Biol,2005,32(4):311-318
[3] Sulkowska M,Sulkowski S,Terlikowshi S, et al. Tumor necrosis factor α induced emphysema-like pulmonary tissue rebuilding:Changes in type Ⅱ alveolar epithelial cell[J].Pol J Pathal,1997,48:179
[4] 安立,张洪玉,庞宝森,等. 基质金属蛋白酶在阻塞性肺气肿大鼠模型中的表达及部分细胞因子的水平[J].中华内科杂志,2003,42(3):181
[5] 张永,程德云,王慧等.慢性阻塞性肺疾病大鼠肺内白细胞介素-和肿瘤坏死因子-α 与气道炎症的研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359
[6] Gruber BL,Marchese MJ,Kew RR.Transforming growth factor beta 1 mediates mast cell chemotaxis[J].J Immunol,1994,152(12):5860-5867
[7] Olsson N,Piek E,Sundst rom M ,et al.Transforming growth factor beta mediated mast cell migration depends on mitogen-activated protein kinase activity[J]. Cell Signal,2001,13(7):483-490
[8] Fong CY,Pang L,Holland E,et al.TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE2 release in human airway smooth muscle cells[J].Am J Physiol Lung Cell Mol Physiol,2000,279(1):201-207
[9] Takizawa H,Tanaka M,Takami K et al.Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)[J] . Am J Respir Crit Care Med,2001:163:1476-1483
[10] White AC,Das SK,Fanburg BL.Reduction of glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth Factor-1[J].Am J Respir Cell Mol Biol, 1992, 6:364-368
[11] 韩玲,许建英.慢性阻塞性肺疾病患者气道上皮细胞 TGF-β 表达的研究[J].山西医科大学学报,2007,38(1):31-33
[1] Taupin D, Pedersen J,Familari M,et al.Augmented intestinal trefoil factor (TFF3)and loss of pS2 (TFF1)expression precedes metaplastic differentiation of gastric epithelium[J].Lab Invest,2001,81:397-408
[2] Dos Santos SE,Ulrich M,Doring G,et al. Trefoil factor family domain peptides in the human respiratory tract[J].J Pathol,2000,190:133-142
[3] Thim L.Trefoil peptides:from structure to function[J].Cell Mol Life Sci, 1997,53(11-12):888-903
[4] Wiede A, Jagla W, Welte T et al. Localization of TFF3, a new Mucus-associated peptide of the human respiratory tract[J].Am J Respir Crit Care Med 1999, 159:1330-1335
[5] LeSimple P, Seuningen IV,Buisine MP et al.Trefoil Factor Family3 Peptide Promotes Human Airway Epithelial Ciliated Cell Differentiation[J].Am J Respir Cell Mol Biol 2007,(36):296–303
[6] Graness A, Chwieralski CE, Reinhold D,et al. Protein kinase C and ERK activat ion are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion[J].J Biol Chem,2002,277:18440-18446
[1] Ryan JW,Ryan US. Pulmonary endothelial cells[J].Am J Med,1977,63:595
[2] Tierney DF.Intermediary metabolism of the lung[J].Ann Rev Physiol, 1974,36:209
[3] Polak JM,Bloom SR. Peripheral localization of regulatory peptides as a clue to their function[J].J Histochem Cytochem, 1980,28(8):918-924
[4] Ryan JW. Processing of endogenous polypeptides by the lungs[J]. Ann Rev Physiol,1982,44:241-255
[5] Lucchini RE,Facchini F,Turato G,et a1.Increased VIP-positive nerve fibers in the mucous glands of subjects with Chronic bronchitis[J].Am J Respir Crit Care Med,1997,156(6):1963-1968
[6] Groneberg D A,Springer J,Fischer A.Vasoactive intestinal polypeptide as medlater of asthma [J].Pulm Pharmcol Ther,2001,14(5):391-401
[7] Palmer JB. VIP and PHM and their role innonadrenergic inhibitory responses in isolated human airways[J].J appl Physiol,1986,61(4):1322-1328
[8] 伍倩.引经药对P-糖蛋白的影响[J].现代预防医学,2005,32(7):855-856
[2] Pauwels RA, Buist AS,Calverley PM, et al. GlobalStrategy for the diagnosis mana gement and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease [GOLD] Workshop summary[J]. Am J Respir Crit Care Med, 2001, 163(5): 1256-1276
[3] National Heart,Lung,and Blood Institute. Morbidity & mortality:chartbook on cardiova scular, lung,and blood diseases. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Institutes of Health, 1998. Available from:URL:www. nhlbi. nih. gov/ nhlbi/ seiin// other/ cht-book / htm .
[4] 赵鸣武.慢性阻塞性肺疾病认识的进展及问题. 临床内科杂志,2004,21(1):21-22
[5] 董碧蓉.慢性阻塞性肺疾病的诊治进展[J].现代临床医学,2007,33(1) 增刊:13-16
[6] 程显声,武阳本,李景周等.吸烟者慢性阻塞性肺病易患因素的研究[J].中华结核和呼吸杂志,1999,22:602-604
[7] 史清明,张宜文,倪进发.慢性阻塞性肺病危险因素的病例对照研究[J]. 安徽预防医学, 2002,8(4):209-210
[8] MoolgavkarSH.Air pollution and hospital admissions for chronic obstructive pul monary disease in three metropolitan areas in the United States[J]. lnhal Toxico1, 2000,12(Suppl 4):75-90
[9] 张金良,周瑾,谢绍东等. 北京市空气质量与每日居民死亡关系的研究[J]. 环境与健康杂志,2003,20(2):75-78
[10] Peinado VI, Barbera JA, Abate P,Ramirez J, Roca J,Santos, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med 1999, 159: 1605-1611
[11] Finkelstein R,Fraser RS,Ghezzo H,et al. Alveolar inflammation and its relation to emphysema in smokers[J].Am JRespir Crit Care Med,1995,152(5Pt1): 1666-1672
[12] Saetta M ,Di Stefano A, Turato G, et a1. CD8+T-ymphocytes in the peripheral airways of smokers with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med,1998,157(3Pt1):822-826
[13] 张永,程德云,王慧等.慢性阻塞性肺疾病大鼠肺内白细胞介素8和肿瘤坏死因子α与气道炎症的研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359
[14] Keatings VM, Collins PD, Scott DM, et a1.Diferences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma [J].Am J Respir Crit Care Med, 1996,153(2):530-534
[15] Pang G, OrtegaM ,Zighang R,et al. Autocrine modulation of IL-8 production by sputum neutrophils in chronic bronchial sepsis[J]. American Journal of Respiratory and Critical Care Medicne,1997,155(2):726-731
[16] LundbladL K,Thomp son-Figueroa J, Leclair T,et al.Tumor necrosis factor alpha over-expression in lung disease:a single cause behind a complex phenotype[J]. Am J Resp ir Crit CareMed,2005,171:1363-1370
[17] 黄勤欢,张扣兴,薛青.慢性阻塞性肺疾病患者血清中黏附分子、肿瘤坏死因子和白介素-8的变化[J].现代中西医结合杂志,2004,13:3096-3103
[18] Utsugi M,Dobashi K,Kaga Y,etal.Glntathione redox regulates lipopolysac charide induced IL-12 prodnction through P38 mitogen activated protein kinase activation inhuman monocytes: role of glutathione redox in IFN-gamma priming of IL-12 production[J].J Leukoo Biol,2002,71:339-347
[19] Dobashi K,Aihara M,Araki T,et al. Regulation of LPS induced IL-12 production by IFN-gmnma and IL-4 throngh intracellular glutathionestatus in human alveolarmacrophages[J].Clin Exp Immunol,2001,124:290-296
[20] Terence S,Rhian HO,Angshu B,et a1.Respiratory viruses,symptoms,and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,164(9):1618-1623
[21] Roland M,Bhowmik A,Sapsford RJ,et a1.Sputum and plasma endot helia1 levels in exacerbations ofchronic obstructive pulmonary disease[J].Thorax, 2001, 56:30-35
[22] 牟小芬,田亚平,郭广宏等.老年COPD稳定期患者病程发展与细胞因子等因素的关系[J].中国临床康复,2005,9(7):88-90
[23] Charles KIII , Robert J H ,Zhu Z ,et al. Airway Hyperresponsiveness and Airway Obstruction in Transgenic Mice[J].Am J Respir Cell Mol Biol,2000,22 (3):289-295
[24] Gilrnour PS. Rahman L, Hayashi S, et al.Adenoviral EIA Primes alveolar epitbethal cells to PM(10)-induced ranscrip tion of interleukin-8[J].Aml Physical lung cell Mol Physical,2001,281:598-606
[25] 董平,孔令敏,陈文靖等.COPD 急性发作期白介素-8 、肿瘤坏死因子-α的表达与预后分析[J].中国厂矿医学,2002,15(2):99-100
[26] Yamamoto c,Yoneda T,YoshikawaM,et a1. Airway inflammation in COPD assessed by sputum levels of interleukin-8[J]. Chest,1997,112 (2):505-510
[27] Gillissen A,JaworskaM,OrthM,et al. Nacyatelyn,a novel lysinealt of N-acerylcysteine to angrnent cellular antioxichan defence in virro[J]. RespirMed, 1997,91:159-168
[28] 熊彬,邓俊,熊瑛.慢性阻塞性肺疾病患者血清IL-6、IL-8、IL-18的水平及意义.四川医学[J],2005,26(10):1082-1083
[29] Woodruff PG, Koth LL, Yang YH, et al. Adistinctive alveolar macrophage activation state induced by cigarette smoking [J]. Am J Resp ir Crit Care Med, 2005, 172: 1383 -1392
[30] Baraldo S, Bazzan E, Turato G, et al. Decreased exp ression of TGF-beta type II receptor in bronchial glands of smokers with COPD[J]. Thorax, 2005, 60: 998 -1002
[31] 韩玲,,许建英.慢性阻塞性肺疾病患者气道上皮细胞TGF-β1 表达的研究[J],山西医科大学学报,2007,38(1):31-33
[32] Dalai S,Imai K,Mercer B,et a1.A role for collagenase (matrix metallo prote inase-1) in pulmonary emphysema[J].Chest,2000,117:227s-228s
[33] Jeffery PK, Lymphocytes,chronic hronchitis and chronic obstructive primonary disease [J].Novartis Found Symp,2001,234:149-161
[34] 李雯,徐永健,魏华平等.白介素-4和白介素-6在慢性阻塞性肺病肺组织中的表达[J].中国组织化学与细胞化学杂志,2001,10(4):425-428
[35] 彭建萍.细胞因子与慢性阻塞性肺疾病[J].江西医学院学报,2005,45(4):148-149
[36] Taraseviciene-Stewart L, Scerbavicius R,Choe KH,et al. Ananimalmodel of autoimmune emphysema[J].Am J Respir Crit CareMed,2005,171:734-742
[37] Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J]. Am J Respir Crit Care Med, 2001, 163: 1256 – 1276
[38] Lomas DA, Mahadeva R. Alpha 1antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for treatment[J].J Clin Invest,2002,110:1585-1590
[39] Lin S, Roche N, Oliver BG,et al. Balance of matrix metalloprotease-9 and tissue inhib itor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10[J].Am J Respir Crit Care Med.2000,162:1355-1360
[40] Chapman HA Jr ,Shi GP. Protease injury in the development of COPD[J].Thomas A. Neff Lecture.Chest,2000,117:295-299
[41] Lomas DA, Mahadeva R. Alpha 1 antitrypsin polymerisation and the serpinopathies: pathobiology and prospects for treatment[J].J Clin Invest,2002,110:1585-1590
[42] Lin S, Roche N, Oliver BG, et al. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10[J].Am J Respir Crit Care Med. 2000, 162:1355-1360
[43] Rennard S,Decramer M,Calverley PM,et al Ampact of COPD in North America and Europe in 2000 :subjects perspective of Confronting COPD International Survey[J]. Eur Respir J,2002;20:799-805
[44] Tetley TD.Macrophages and the pathogensis of COPD[J].Chest,2002, 121:156s-159s
[45] Koyama H,Geddes DM.Gene,oxidative stress and the risk of chronic obstru ctive pulmonary disease[J].Thorax,1998,53(Suppl2)10-14
[46] MacNeeW.Oxidants/antioxidants and chronic obstructive disease:pathogenesis to therapy[J].Novatis Found symp.2001,234:169-185
[47] Sauleda J.Garcia-paliner FJ,Gonzalez G,et al. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease,asthma and chronic arthritis[J]. Am J Respir Crit Care Med,2000,161:32-35
[48] Repine JE,Bast A,Lankhorst 1.The oxidative stress Study Group.Oxidative stress in chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1997,156: 341-357
[49] 蔡珊 ,陈平 .感染与慢性阻塞性肺疾病 [J].国外医学呼吸系统分册 , 2005, 25(6): 412-413
[50] Prieto A, Reyes E ,Bernstein ED,et a1. Defective natural killer and phagocytic activeties in chronic obstructive pulmonary disease are restored by glycophosphopepica l (Inmunoferon)[J].Am J Respir Crit Care Med, 2001, 163:1578-1583
[51] Hunter MH, King DE. COPD: Management of Acute Exacerbations and Chronic Stab le Disease [J].Am Fam Physician,2001,64:603-612
[52] Miravitlles M,Espinosa C,Fernandez-Laso E,et a1.Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD[J].Chest,1999,116:40-46
[53] Eller J,Ede A,Schaberg T,et a1.Infective exacerbations of chronic bronchitis,Relation between bacterial etiology and lung function [J].Chest,1998,113:1542-1548
[54] Ianni, Majore S, Arzani D, et al.CCR2 and CCR5 gene polymorphism in children with recurrent respiratory infections[J].RespirMed,2001,95(5):130-132
[55] Seemungal TA,Harper-Owen R,Bhowmik A,et a1Respiratory viruses,symptoms and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2001,164: 1618-1623
[56] Pietila MP, Thomas CF. Inflammation and infection in exacerbations of chronic obstructive pulmonary disease[J].Semin Respir Infect,2003,18: 9-16
[57] Takabatake N ,Nakamura H ,Abe S ,et al . Circulating leptin in patients with chronic obstructive pulmonary disease[J].Am JRespir Crit Care Med, 1999,159 (4 Pt 1):1215-1219
[58] Yasuda N, Gotoh K, Minatoguchi S, et al. An increase of soluble Fas, aninhibitor of apoptosis, associated with progression of COPD[J]. Respir Med,1998, 92(8):993-999
[59] Shore S,Kobzik L ,Long NC. Increased airway responsiveness to inhaled methacholine in a rat model of chronic bronchitis[J].AmJ Respir Crit Care Med. 1995, 151: 1931 – 1938
[60] 许建英,杜永成,赵鸣武等.大鼠慢性阻塞性肺疾病模型的建立[J].中国病理生理杂志,2000,16:383-384
[61] 许三林,吴人亮,陈春莲等.E-cadherin在吸烟小鼠气道上皮损伤修复中表达的研究[J].中华结核和呼吸杂志,1999,22:417-419
[62] 赵玉霞,于润江. 吸烟对脂质过氧化系统及a1-抗胰蛋白酶的影响[J].中华结核和呼吸杂志,1998 ,21 :218-219
[63] Marino G.Vitamin C helps cigarette-smoking hamster[J]. Science News, 1994, 146 :86-86
[64] 迟春花. 烟草雾吸入导致COPD 机制的实验研究——大鼠Clara 细胞结构及其分泌蛋白的变化[J].心肺血管病杂志,2000,(3):224-227
[65] 黄念秋,吴善.现代老年呼吸病学[M].北京:人民军医出版社,1998:98
[66] Black Wood RA,Moret L,et al.Emphysema induced by intravenously adminis tered endotoxin in an alphal-antitrypsin-deficient rat model[J]. Am Rev Respir Dis, 1984, 130:231-236.
[67] Stolk J , Rudolphus A ,Davies P ,et al. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysa ccha ride in the hamster[J].JPathol,1992,167:349-356
[68] 许浒,熊密,黄庆华等.细菌感染导致慢性阻塞性肺疾病[J].中华结核和呼吸杂志, 1999,22:739-742
[69] Tavares JL ,Wangoo A ,Dilworth P ,et al Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages[J].Respir Med, 1997, 91:31-39
[70] Li D ,Godfky R ,Rogers AV ,et al .Endotoxin-induced airway intro-epithelial neutrophilia. Goblet cell hyperplasia and metaplasia in the rat :a light and electron microscopic study[J].Eur Respir J,1996,9:424
[71] 马楠,崔德健,梁延杰等. 气道内注入脂多糖法建立大鼠慢性支气管炎模型[J].中华结核和呼吸杂志,1999,22:371-372
[72] Stockly RA. Protease/ Antiprotease : Pathogenesis and role in therapy[J] . Clinical Pulmonary Medicine ,1998 ,5:203-210
[73] 张旭晨,阮英茆,徐新林等. 应用弹性蛋白酶复制金黄地鼠肺气肿模型[J].天津医药, 1999,27:536-537
[74] 张宏,孟亚娟,斯琴等. 烟雾吸入对地鼠弹性蛋白酶性肺气肿的影响[J].实验动物科学与管理,1999,16(4):1-5
[75] 曾勉,郭禹标,谢灿茂等. 猪胰弹性蛋白酶肺气肿模型复制的实验研究[J].现代康复, 2001,5(3):59-60
[76] Hoedal JR,Niewoehner DE.Cigarette smoke inhalation potentiates elastase induced emphysema in hamsters[J]. Am Rev RespirDis,1983,127:478-481
[77] Juanita HJ,Vernooy, Mieke A,et al. Long-Term Intratracheal Lipopolysacc haride Exposure in Mice Results in Chronic Lung Inflammation and Per sistent Pathology[J].Am J Respir.Cell Mol.Biol,2002,1:1592-1596
[78] Jan S, Arjan R ,Philip D.Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster[J].Journal of pathology,1992,167:349-356
[79] Hoedal JR ,Niewoehner DE. Cigraette smoke inhalation potentiates elastase-induced emphysema in hasnters[J]. Am Rev Respir Dis, 1983, 127: 478-481
[80] 宋一平,崔德健,茅培英,等. 慢性阻塞性肺病大鼠模型的建立及药物干预的影响[J].中华内科杂志,2000,39:556
[1] 单丽囡,刘小虹,李兰铮等. 从痰瘀论治慢性阻塞性肺疾病体会[J].湖南中医杂志, 2005,21(2):92
[2] 张文江 ,苗青 ,张燕萍等 .许建中学术思想经验传承研究 [J].中华中医药杂志,2007,22(12):854-856
[3] 傅曙华. 慢性阻塞性肺疾病病因病机及治法探讨[J]. 湖南中医杂志, 2003,19(4): 3-4
[4] 史锁芳, 曹世宏,徐丽华等.清源化痰颗粒治疗慢性阻塞性肺病发作期的临床研究[J].南京中医药大学学报,2000,16(3):8l-82
[5] 黄礼明. 试论痰、瘀、虚在慢性阻塞性肺病辨治中的重要性[J].贵阳中医学院院报,2000,22(1):5-7
[6] 董滟. 中医治疗 COPD 稳定期的优势评析[J].中医药学刊,2004,22(1):155
[7] 万文蓉. 论阳虚痰瘀是慢性阻塞性肺疾病的基本病机[J]. 中医药学刊, 2005,23(9): 1672
[8] 曹红九,王东华.益气活血法治疗慢性阻塞性肺病[J].湖北中医杂志,2001,23(1):27
[9] 张弛,林如平,刘洪等.鱼腥草注射液对慢性阻塞性肺疾病患者炎症细胞因子与肺功能的影响[J].中国中医药科技,2006,13(5):294-296
[10] 许建中.慢性阻塞性肺疾病中医诊治探讨[J].江苏中医药,2006,27(7):4-5
[11] 刘文萍,丁海菊.中西医结合治疗慢性阻塞性肺疾病急性期疗效观察[J].中国医院用药评价与分析,2007,7(1):58-59
[12] 李康 ,张晓云 .中西医结合治疗慢性阻塞性肺疾病急性加重期 28 例 [J].中医杂志,2007,48(3):242-243
[13] 陈 利 平 . 中西医结合治疗慢性阻塞性肺疾病急性发作期 60 例 [J]. 河南中医2006,26(1):64-65
[14] 荆小莉,王东平,李欣等.清肺化痰祛瘀方治疗慢性阻塞性肺疾病急性加重期的研究[J].中国中西医结合急救杂志,2006,13(5):270-272
[15] 陈斯宁,黄美杏,古立新等.清肺化痰颗粒治疗慢性阻塞性肺疾病急性加重期痰热郁肺证临床观察[J].广西中医药,2007,30(1):8-10
[16] 李小春,罗建辉,王金凤.痰热清注射液治疗慢性阻塞性肺疾病急性发作疗效观察[J].中国中医急症,2006,15(7):695-697
[17] 朱 频 , 郦 永 平 . 慢 性 阻 塞 性 肺 病 急 性 加 重 期 中 医 证 治 规 律 探 讨 [J]. 河 南 中 医 , 1998,18(6):369
[18] 张元兵,洪广祥.“肺与大肠相表里”理论在慢性阻塞性肺疾病急性发作期的应用[J].江西中医药,2000,31(3):15-16
[19] 林嬿钊，韩云，李芳.通下法配合无创通气治疗慢性阻塞性肺疾病急性加重期呼吸衰竭 15 例[J].新中医,2005,37(1):41-42
[20] 王学东.慢性阻塞性肺疾病中医治疗[M].江苏科学技术出版社.2002:102
[21] 方堃, 石占利, 李志会. 通腑平喘汤联合机械通气治疗慢性阻塞性肺疾病并发呼吸衰竭的临床疗效观察[J].中国中西医结合急救杂志,2006 ,13(5):291-293
[22] 沈晓强,鲍志坚,胡旭等.冬虫夏草治疗肺肾两虚证慢性阻塞性肺疾病[J].浙江中西医结合杂志,2005,15(2):84-85
[23] 王莒生,苑惠清,刘薇.参灵胶囊治疗慢性阻塞性肺部疾病缓解期的临床研究[J].北京中医,2006 ,25 (9):518-520
[24] 雷明盛,唐淑明,谭芳.参芪肺宝治疗慢性阻塞性肺疾病稳定期 30 例临床观察[J].江西中医药,2006, 37(8):43
[25] 孙志佳.温补肺肾法治疗慢性阻塞性肺疾病的理论与临床探讨[J].中医药管理杂志,2006 ,14(5):56-58
[26] 张贻雯,刘刚.益气补肾汤提高慢性阻塞性肺疾病患者体液免疫的研究[J].实用中西医结合临床,2006,6(5):19-20
[27] 王胜,张念志,季红燕等. 益肺健脾中药对慢性阻塞性肺疾病气道炎症作用的研究[J].中国中西医结合杂志,2002,22(6)462
[28] 刘小虹 ,刘琼 .培土生金法在慢性阻塞性肺疾病缓解期的应用研究 [J].新中医 , 2002,34(10):18-19
[29] 王胜,季红燕,张念志等.益肺健脾中药改善慢性阻塞性肺疾病患者肺功能及营养状况[J].中国临床康复,2005,9(31):141-143
[30] 司东波.调理脾胃法对慢性阻塞性肺疾病预后的影响 [J].中国中医急症 ,2005,15 (8):838-839
[31] 殷四祥,汪陆庆,王章桂.生脉注射液对慢阻肺发作期肺功能及血气分析的影响[J].中医药临床杂志,2006,18(6):557-558
[32] 崔焱,梁直英,董竞成.活血化瘀方治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中国中西医结合杂志,2005,25(4):327
[33] 吴惕虎.慢性阻塞性肺病以瘀血论治的临床观察[J].河北中医,1997,19(3):17
[34] 林育华.活血化瘀法治疗慢阻肺 95 例临床观察[J].新中医,1998,30(2):33
[35] 黄美虹,韩云.川芎嗪注射液对慢性阻塞性肺疾病急性加重期主要结局指标的影响[J].现代中西医结合杂志,2004,13(15):2002-2003
[36] 张立山,武维屏,董安铭等.肺康方治疗慢性阻塞性肺疾病肺动脉高压的临床研究[J].北京中医药大学学报, 2003,36(3):70-73
[37] 曾飞球,刘建新,林夏飞.经络导平佐治慢性阻塞性肺疾病的临床研究[J].中国老年学杂志,2004,7(24):605
[38] 陈钦 ,谢田钢 ,金先桥 . 推拿治疗慢性阻塞性肺疾病的疗效 [J].中国临床康复,2006,10(7):10
[39] 孙树起, 郭丕春. 耳针埋穴法治疗 COPD 并少量咯血临床观察[J].中华实用中西医杂志,2004,4(17):16
[40] 潘小峰,高祥福.红花汤雾化吸入对慢性阻塞性肺病缓解 30 例观察[J]. 江中医杂志 ,2000,35(50):216
[41] 赵湘,陈铭华,胡雪梅等.气道阻塞性疾病雾化吸入疗法进展[J].实用中西医结合杂志,1997,16(3):293
[42] 王玉光,许世芳.清开灵注射液支气管肺泡灌洗治疗慢性阻塞性肺病 30 例[J].山东中医杂志,2000,19(5):274-275
[43] 王雪琴,岳留枝.中西医结合康复治疗仪治疗慢支肺气肿 64 例临床分析[J].河南医药信息,1997,5(8):46-47
[44] 郑彩霞,王洪刚,刘振安.穴位贴敷为主治疗慢性阻塞性肺疾病 90 例[J].中医研究,2005,18(10):36-37
[45] 庞巧玲,鲍正宏.穴位注射和中药贴敷防治慢性阻塞性肺疾病 180 例[J].中国民间疗法,2005,13(2):31
[46] 季红燕,张念志,陈炜等.参七虫草胶囊对慢性阻塞性肺疾病大鼠模型细胞因子的影响[J].安徽医科大学学报,2003,38(2):272-274.
[47] 连金诗.黄芪注射液对 COPD 患者 T 细胞亚群影响的临床观察[J]. 黑龙江中医药杂志, 2002,5:9-10
[48] 钟冬梅.生脉注射液改善慢性阻塞性肺病患者免疫功能的疗效观察[J].华西药学杂志,2002,17(4):315
[49] 李素云,李健生,马利军等.益气养阴活血化瘀法对慢性阻塞性肺疾病稳定期免疫功能的影响[J].河北中医,2001,23(12):899
[50] 田正鉴,邹新蓉.慢性阻塞性肺疾病扶正固本价值评述[J].中医药学刊, 2001, 19: 236
[51] 毛兵,李廷谦,迟焕海等.玉屏风散颗粒治疗慢性阻塞性肺病的临床研究[J].成都中医药大学学报,1999,22(2):16-19
[52] 张念志,赵丽萍,卓秀珍等. 参七虫草胶囊治疗慢性阻塞性肺疾病的大鼠模型肿瘤坏死因子-amRNA 基因表达的影响[J].中国中医急症,2004,(13)2:107-108.
[53] 张颖,李廷谦,王刚等. 痰热清注射液治疗慢性阻塞性肺疾病急性加重期(痰热阻肺证)的随机对照试验[J].中国循证医学杂志,2004,4(5):300
[54] 李素云,程先宽,李建生等.通塞颗粒对老年 COPD 急性加重期炎性细胞因子的影响[J].辽宁中医杂志,2003,30(8):624-625
[55] 耿晓照,雷明盛.嗽宝合剂对 COPD“肺气虚证”大鼠血清 TNF-α 及 IL-8 含量变化影响[J].贵州医药,2005,29(9):782-785
[56] 张朝宁,吴立文,孙杰等. 益肾通肺汤对 COPD 大鼠血清 IL-8、TNF-α 的影响[J].甘肃中医学院学报,2006,23(1):23-25
[57] 王文生,雷明盛,张敏.参芪肺宝对 COPD“肺气虚证”大鼠血清 TNF-α 及 IL-8 含量变化的影响[J].江西中医学院学报,2007,19(1):72
[58] 张伟,李刚,张心月.小青龙汤对慢性阻塞性肺疾病大鼠核因子 κB 和 γ-谷氨酰半胱氨酸合酶表达的干预作用[J].浙江中医药大学学报,2006,30(5):457-460
[59] 谢强敏,方理本,张洪泉.哮喘和 COPD 的新概念及新药[M] .北京:科学出版社,2003:52-71
[60] 王凤仪,李生财,李立等. 敦煌古方“紫苏煎”对慢性支气管炎大鼠血清、肺组织中SOD、MDA、NO 含量的影响[J].甘肃中医学院学报,2003,20(2):14-17
[61] 杨牧祥,方朝义,谷振勇等.咳喘宁胶囊对慢性支气管炎大鼠血清、肺组织及支气管肺泡灌洗液 SOD、CAT 活性及 MDA 含量的影响[J].中国中医基础医学杂志,2002,8 (1):14-18
[62] 李原青,李亚光.加减补肺汤抗氧化治疗慢性阻塞性肺疾病的实验研究[J] .江西中医学院学报,2004,16(4):61-62
[63] 张葡萄,陈真如.复方丹参注射液对慢性肺心病患者血中脂质过氧化物及抗氧化物酶活性的影响[J].中国中西医结合杂志,1994,14 (8):474-477
[64] 朱渊红,应可净,蔡宛如,等.黄芪注射液对慢性阻塞性肺疾病急性加重期氧化/抗氧化失衡的影响[J],中国中医急症,2004,13(9):597
[65] 赵长鹰,洗英森,孟辉等. 金水六君煎对慢性支气管炎小鼠血清超氧化物歧化酶活力和丙二醛含量的影响[J].中国中西医结合杂志,2001,21(11):843-844
[66] 马利军,吴纪珍,牛红丽等. 老年 COPD 患者急性发作期与缓解期细胞因子及 SOD、MDA 变化[J].中国老年学杂志,2003,23(3):191-192.
[67] 张伟,邵雨萌,张心月.人参蛤蚧散对慢阻肺模型大鼠核因子 κB 和 γ-GCS 表达的干预作用[J].山东中医药大学学报,2006,30(5):399-401
[68] 刘力, 唐岚, 徐德生等.生地注射液对脂多糖诱导大鼠肺部炎症的影响[J].中国中药杂志,2007,32(6):526-528
[69] 曾征,刘雨星.穴位敷贴对实验性慢性支气管炎的血液流变学影响[J].中医外治杂志,1999,8(3):5-6
[70] 张伟,周兆山,贾新华. 养血益气法对慢性支气管炎大鼠血液流变学的影响[J].中国中医药科技,2002,9(2):951
[71] 郑洁.“治肺不远温”在慢性阻塞性肺疾病(COPD)急性发作期的临床研究[J] .江西中医药,2000,3(6):20-22
[72] 赵湘,陈明华,胡梅雪等. 雾化吸入“复方三拗液”治疗慢性阻塞性肺疾病的临床研究[J].中西医结合实用临床急救 1998,5(6)∶241-44
[73] 江淳涓,毕小利,王跃. 生地注射液对慢性阻塞性肺疾病患者血液流变学及肺功能的影响[J].实用中医药杂志,2002,18(8):7-8
[74] 吴景硕,张琳.络泰对慢性阻塞性肺疾病患者血液流变学及血气分析的影响[J].中草药,2002,33(9):832-833
[75] 林春龙,张珍祥,徐永健.川芎嗪和尼群地平配伍治疗慢性阻塞性肺病的机制探讨[J].中国中西医结合杂志,2001,21(1):28-30
[76] 雷明盛,唐淑明,张敏.参芪肺宝合剂对 COPD“肺气虚证”大鼠的作用及对血浆 ET的影响[J],江西中医学院学报,2006,18(4):79-80
[77] 汤泰秦,刘晓妍,侯励.肺压宁胶囊治疗慢性阻塞性肺病 73 例疗效观察[J].暨南大学学报(医学版),2002,23(12):42
[78] 林春龙,张珍祥,徐永健等. 川芎嗪与尼群地平配伍对慢性阻塞性肺病患者血流动力学的影响[J].中国中西医结合杂志,2001,21(3):183-185.
[1] Han SB ,Park SH ,Lee KH , et al.Polysacchar deslated from the radix of plat ycodon grandiflorum selectively actvates B cells and macrop hages but not T cells[J].Immunol,2001,1(11):1969
[2] Choi CY, Kim J Y , Kim YS , et al.Augmentation of macrophage functions by an aqueous extract isolated from Platycodon grandiflorum[J].Cancer Lett , 2001, 166(1):17
[3] Choi CY , Kim J Y, Kim YS ,et al .Aqueous extract isolated from platycodon grandiflorum elicits the release of nitricoxide and tumor necrosis factor-alp ha frommurine macrophages[J].Int Immunopharmacol, 2001, 1(6):1141
[4] Wang C,Levis GBS ,Lee EB ,et al .Platycodin D and D3 isolated from the root of platycodon grandiflorum modulate the production of nitricoxide and secretion of TNF-alpha in activated RAW 264.7 cells[J].Int Immnopharmacol, 2004,4(8):1039.
[5] Yoon YD ,Han SB , Kang J S , et al .Toll-like receptor 4 - dependent activation of macrophages by polysaccharideisolated from the radix of Platycodon grandilo rum[J].Int Immunopharmacol,2003,3(13～14):1873
[6] Ahn ks,Noh E J,Zhao H L,et al.Inhibition of inducible nitricoxide synthase and cycloxygenase Ⅱ by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells[J].Life Sciences, 2005, 76(20): 2315
[7] Lee JH. Choi YH,Kang HS,et al.An aquecous extract of Platycodiradix inhibits LPS-induced NF-kappaB nuclear translocation in human cultured airway epithelial cells[J].Int J Mol Med,2004,13(6):843
[8] Kim YP, Lee EB,Kim SY,et al.Inhibition of prostag landin E2 production by platycodin D isolated from the root of platycodon grandiflorum[J].Planta Med,2001,67(4):362
[9] 高学敏.中医药学高级丛书——中药学[M].北京:人民卫生出版社,2000:1217
[10] 王本祥.现代中药药理学[M].天津:天津科学技术出版社,1997:949
[11] Shin C Y,Lee WJ,Lee EB,et a1Platycodin D and D3 increase airway mucin releae in vivo and in vitro in rats and hamstersf [J].PIanta Med,2002,68(3):221
[12] Lee KI,Jeong HG.Protective efect of Platycodi radix on carbon tetr achlo ride — induced hepatotoxicity[J].Food Chem Toxicol,2002,40(4):5l7
[13] Lee KJ,Kim JYJung KS,et a1Suppressive efects of Platycodon gran dif lor um on the progress of carbon tetrachloride—induced hepatic fibrosis[J].Arch Pharm Res,2004,27(12):1238
[14] Lee KJ,Choi CY,Chung YC,et a1.Protective efect of saponins derived from roots of Platycodon grandiflorum on tert—butyl hydroperoxide—induced oxidative hepatotoxicity[J].Toxicol Lett.2004,147(3):271
[15] Lee KJ,You HJ,Park SJ,et a1.Hepatoprotective efleets of PIatyc—edon grandiflomm on acetaminophen -induced liver damage in mice [J].Cancer Lett,2001,174(1):73
[16] Kim K ,Seo E ,Lee Y , et al .Effectof dietary platycodon randiflorum on the improvement of insulin resistance in obese Zucker rats[J].J Nutr Biochem, 2000,11(9):420
[17] 高云芳,陈超,张海祥等.桔梗总皂苷对大鼠高脂血症的影响[J].中草药, 2000, 31 (10):764
[18] Lee JY,Yoon JW, Kim CT et a1.Antioxidant activity of phenylpropanoid esters isolated and identified from Platycedon grandiflorum A DC[J]. Phytochem istry,2004,65(22):3033
[19] 东野长新,东野广刚.化痰平喘合剂治疗慢性阻塞性肺疾病 30 例[J].河北中医,2004,26(9):672
[20] 赵菁华,杨广源,白燕中西医结合治疗慢性阻塞性肺疾病急性发作 42 例临床观察[J],内蒙古中医药,2007,10:19-20
[21] 陈亚华,陈淑芬,王梅,桔梗射干煎液治疗小儿急性扁桃体腺炎 106 例临床观察[J],黑龙江医药,1999,22(2):43
[22] 金峰.桔梗止咳汤治疗急性气管-支气管炎疗效观察[J].中医研究,1997,10(2):41
[23] 梁燕.克咳胶囊治疗急性气管-支气管炎的临床观察[J].贵阳中医学院学报,1997, 19 (3):32
[24] 杨传英 .车前桔梗汤治疗慢性支气管炎 96 例疗效观察 [J].中国中医药信息杂志,2001,8(3):66-67
[25] 曹红洲. 固本止咳汤治疗慢性支气管炎 45 例[J].河南中医,2000,20(4):45
[26] 朱东碧.中西医结合治疗慢性支气管炎急性发作[J].浙江中西医结合杂志, 2000, 10 (1):32
[27] 瞿结宗.降气平喘汤治疗支气管哮喘 98 例[J].陕西中医,2000,21(10):450
[28] 朱永忠.加减阳和汤治疗寒性哮喘 30 例[J].陕西中医,2000,21(10):49
[29] 沈志忠.自拟二百桔梗白芨汤治疗支气管扩张 32 例[J]. 四川中医,1995,13(8): 39
[30] 闫燕.经方治疗小儿急性病毒性肺炎 101 例[J].国医论坛,2000,15(1):12
[31] 李新成.中西医结合治疗支原体肺炎 48 例[J].湖北中医杂志, 2000,22(4):19
[32] 杨修策.桔梗汤加味治疗肺脓肿一得[J].光明中医,2000,15(4):30-31
[33] 李良辉.中西医结合治小儿肺脓疡临床观察[J].江西中医药,2000,31(2):44
[34] 赵玉洁中西医结合治疗肺脓肿疗效分析[J].贵阳中医学院学报,1997, 19 (2):13-14
[35] 张绍文.达肺冲剂治疗肺结核临床疗效观察[J].中医药学报,2000,(3):18-19
[36] 蓝世隆.抗痨丸治疗结核病 124 例疗效观察[J].新中医,1999,31(1):32-33
[37] 赵孟碧.百合固金汤治疗肺结核 48 例[J].实用中医内科杂志,2002,16(3):141
[38] 曹利平,闻新丽.中西医结合治疗肺心病急性加重期 132 例[J].陕西中医,2002,23 (4):291-292
[39] 陈全寿.肺心汤治疗肺心病 80 例[J].实用中医内科杂志,1998,12(1):38
[40] 邱飞,张玉萍.肺间质纤维化的中医治疗[J],新疆中医药,2003,21(2):25-26
[41] 徐淑江.分期辨证治疗煤工尘肺[J].黑龙江中医药,2000,(2):30
[42] 田立岩,杨春霞,段军.中药桔梗治疗矽肺临床疗效观察[J].中国职业医学,2007,34(4):307
[43] 山广志.电化疗合加味桔梗汤治疗肺癌 50 例[J].中国中西医结合杂志,1999,19(5) : 312
[44] 刘兴国.桔梗散合漱口液治疗慢性咽炎 56 例[J].医药论坛杂志,2005,26(12):57
[45] 邓森田.桔梗甘草汤治疗急慢性咽喉炎 48 例[J].陕西中医,1998(19):5
[46] 孙建平.桔梗汤加味治疗咽炎 193 例[J].光明中医,2002,17(4):46-47
[47] 胡炜.双花桔梗茶治疗慢性咽炎 157 例体会[J].浙江中西医结合杂志, 2002,12(6):370
[1] 施怀生.试论中药归经理论及其与体内代谢过程的关系[J]. 山西中医,1996,12 (6): 32-34
[2] 陆光伟.中药归经及其成分在体内的分布[J].中成药研究,1984,(5):38-39
[3] 郭顺根,牛建昭,贲长恩等.3H-川芎嗪在动物体内分布的放射自显影研究[J].中国医药学报,1989,4(3):17-21
[4] 郭顺根,贲长恩,牛建昭等.3H-川芎嗪在动物体内分布与排泄的定量研究[J].中国医药学报,1989,4(4):22-25
[5] 郭顺根,牛建昭,贲长恩等.3H-白首乌总甙在动物体分布的放射自显影研究[J].中国医药学报,1989,4(5):17-20
[6] 牛建昭,郭顺根,贲长恩等.3H-白首乌总甙在动物体内分布与排泄的定量研究[J].中国医药学报,1989,4(6):30-32
[7] 郭顺根,贲长恩,赵丽云等.3H-栀子总甙整体放射自显影及图像分析与栀子归经的关系[J].北京中医药大学学报,1996,19(4):28-31
[8] 郭顺根,贲长恩,杨美娟等.3H-淫羊藿甙定量分析与淫羊藿归经的关系[J].北京中医药大学学报,1997,20(1):40-43
[9] 徐莲英,戴荣兴,陶建杰等.3H-麝香酮阴道给药途径的探讨[J].中成药研究,1985, (3):5
[10] 沈海葆,叶定江.从中草药化学成分看归经的意义[J].辽宁中医杂志,1985, (3):39-41
[11] 莫启忠,官斌,钱序平等.3H-冰片动力学的研究[J].中成药研究,1982,(8):5-7
[12] 柴立.从微量元素及其配位化合物对组织器官的富集、亲合探讨“归经”的实质[J]. 微量元素,1984,(试刊号):24
[13] 朱梅年,柴立.试论中医“肾”的物质基础——有关微量元素锌、锰的探讨[J].中医杂志,1983,(5):66-68
[14] 徐经采,朱梅年.明目中药的归经与微量元素的关系[J].1987,(2):32-34
[15] 龚跃新,张根海.中药归经理论与微量元素的关系探讨[J].中医药研究,1990, (5):23-25
[16] 王树荣,孙冰,丁国明.中药归经的实验研究[J].中国中药杂志,1994,19(8): 500-502
[17] 孙冰.中药归经研究[J].山东中医学院学报,1994,18(1):2-6
[18] 王树荣,翟继伟,盖英臣等.天麻、桔梗、元胡归经的实验研究[J].上海中医药杂志,1995,(1):44
[19] 李 仪 奎 , 徐 莲 英 , 马 建 平 . 中 药 药 理 和 归 经 关 系 的 统 计 分 析 [J]. 中 药 通 报 ,1998, 13(7):48-50
[20] 高其铭.当归的药理研究与其归经功效关系的探讨[J].中成药研究,1985, (5) :32-34
[21] 徐建民.传统中药甘草的作用机理[J].浙江中西结合杂志,1994,8(增刊):53
[22] 彭成,雷载权.人参皂甙健脾益气作用的实验研究[J].中药药理与临床,1997,13(5): 17-19
[23] 唐学游.试论药物归经的几个问题[J].中医药研究,1992,(2):53-54
[24] 丁荣施.略论中药归经和受体学说[J].广东医学,1986,7(5):28-30
[25] 王海东.归经研究与受体学说的思考[J].湖北中医学院学报,2001,3(3):8-9
[26] 史正新.中药归经与受体学说[J].陕西中医学院学报,1993,16(2):4-5
[27] 贲长恩,郭顺根.中药归经理论研究述评[J].北京中医药大学学报,1999,22(2):2-7
[28] 王世成.从中药归经到导向药物[J].实用中西医结合杂志,1992,5(2):70
[29] 王岚,李东晓.论中药归经引经及其研究方法[J].江西中医学院学报,2002,14 (1):25-27
[30] 伍倩.引经药对 P-糖蛋白的影响[J].现代预防医学,2005,32(7):855-856
[31] 袁昌锦,黄在玲.略论中药归经、引经理论与现代药理受体、载体的关系[J].湖北民族学院学报·医学版,2000,17(1):30-32
[1] 高学敏.新世纪全国高等中医药院校规划教材·中药学[M]. 北京:中国中医药出版社,2002:28
[2] 郭蔼春.黄帝内经素问校注[M]. 北京:人民卫生出版社,1992:1128,331,76,157
[3] 神农本草经辑注[M]. 北京:人民卫生出版社,1995:338,250,108,84,167,48,61
[4] 梁·陶弘景.名医别录[M]. 北京:人民卫生出版社,1986:95,201,199,311
[5] 宋·苏轼,沈括.苏沈良方[M]. 北京:人民卫生出版社,1956::16
[6] 唐·孟诜.食疗本草[M]. 北京:人民卫生出版社,1984:124
[7] 宋·寇宗奭.本草衍义[M]. 北京:人民卫生出版社,1994:134,38,86,91,46
[8] 宋·苏颂.本草图经[M]. 合肥:安徽科学技术出版社,1994:177
[9] 太平惠民和剂局方[M]. 北京:人民卫生出版社,1985:31,46,249,302,308, 38,161
[10] 刘完素医学全书·素问病机气宜保命集[M]. 北京:中国中医药出版社,2006:169
[11] 张元素医学全书[M]. 北京:中国中医药出版社,2006:49,50,
[12] 元·王好古.汤液本草[M]. 北京:人民卫生出版社,1956:11
[13] 明·刘文泰.本草品汇精要[M]. 北京:人民卫生出版社,1982:227,228,229
[14] 明·李时珍.本草纲目[M]. 北京:人民卫生出版社,2004:84,543,1009,982,732,9
[15] 汪昂医学全书·本草备要[M]. 北京:中国中医药出版社,2005:319
[16] 徐大椿医书全集·医学源流论[M]. 北京:人民卫生出版社,1988:165
[1] 尤在泾医学全书·医学读书记[M]. 北京:中国中医药出版社,1999:346
[2] 张元素医学全书·珍珠囊[M]. 北京:中国中医药出版社,2006:72,50,71
[3] 元·王好古.汤液本草[M]. 北京:人民卫生出版社,1956:11,51,29,87,24
[4] 明·陈嘉谟.本草蒙筌[M]. 北京:人民卫生出版社,1988:20
[5] 中国本草全书·第 88 卷·本草洞诠[M]. 北京:华夏出版社,1999:537
[6] 神农本草经辑注[M]. 北京:人民卫生出版社,1995:118
[7] 梁·陶弘景.名医别录[M]. 北京:人民卫生出版社,1986:36,208
[8] 宋·寇宗奭.本草衍义[M]. 北京:人民卫生出版社,1994:46,115
[9] 李时珍.本草纲目[M]. 北京:人民卫生出版社,2004:267,268,92,122
[10] 清·傅青主.傅青主女科[M]. 北京:人民卫生出版社,2006:4
[11] 元·李东垣.珍珠囊补遗药性赋[M]. 上海:上海科学技术出版社,1986:24
[12] 丹溪医集·丹溪心法[M]. 北京:人民卫生出版社,2006:262
[13] 高晓山.中药药性论[M]. 北京:人民卫生出版社,1992:225
[14] 黄宫绣·本草求真[M]. 北京:人民卫生出版社,1987:71
[15] 张璐·本经逢原[M]. 上海:上海科学技术出版社,1959:78
[16] 袁昌锦,黄在玲.略论中药归经、引经理论与现代药理受体、载体的关系[J].湖北民族学院学报·医学版,2000,17(1):30-32
[1] 刘渡舟.分析《伤寒论》几种“载药上浮”的方法[J].陕西中医,1981,2(6):1-2
[2] 宋传荣.浅析《金匮要略》对酒的应用[J].黑龙江中医药,1990,6:49-50
[3] 郝建新.仲景方“药引”初探[J].浙江中医学院学报,1988,12(6):11-12
[4] 陈宝明.刘渡舟教授临证粹要[J].山西中医,1989,5(6):15-17
[1] 李红梅,崔德健,佟欣.熏香烟加气管注内毒素和单纯熏香烟法建立大鼠 COPD 模型[J].中国病理生理杂志, 2002,18(7):808-812
[2] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261
[3] Stolk J , Rudolphus A ,Daviest P ,et al. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster[J].J Pathol,1992,167:349-356
[1] Bazan JF, Timans JC, Kastelein RA, et al. A newly defined interleukin-1 [J]. Nature,1996,379(6566):591
[2] Lappalainen U,Whitsett JA,Wert SE,etal. Interleukin-1 beta causes pulmonary inflammation,emphysema,and airway remodelingin the adult murine lung[J]. Am J Respir Cell Mol Biol,2005,32(4):311-318
[3] Sulkowska M,Sulkowski S,Terlikowshi S, et al. Tumor necrosis factor α induced emphysema-like pulmonary tissue rebuilding:Changes in type Ⅱ alveolar epithelial cell[J].Pol J Pathal,1997,48:179
[4] 安立,张洪玉,庞宝森,等. 基质金属蛋白酶在阻塞性肺气肿大鼠模型中的表达及部分细胞因子的水平[J].中华内科杂志,2003,42(3):181
[5] 张永,程德云,王慧等.慢性阻塞性肺疾病大鼠肺内白细胞介素-和肿瘤坏死因子-α 与气道炎症的研究[J].中国呼吸与危重监护杂志,2003,2(6):355-359
[6] Gruber BL,Marchese MJ,Kew RR.Transforming growth factor beta 1 mediates mast cell chemotaxis[J].J Immunol,1994,152(12):5860-5867
[7] Olsson N,Piek E,Sundst rom M ,et al.Transforming growth factor beta mediated mast cell migration depends on mitogen-activated protein kinase activity[J]. Cell Signal,2001,13(7):483-490
[8] Fong CY,Pang L,Holland E,et al.TGF-beta1 stimulates IL-8 release, COX-2 expression, and PGE2 release in human airway smooth muscle cells[J].Am J Physiol Lung Cell Mol Physiol,2000,279(1):201-207
[9] Takizawa H,Tanaka M,Takami K et al.Increased expression of transforming growth factor-β1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)[J] . Am J Respir Crit Care Med,2001:163:1476-1483
[10] White AC,Das SK,Fanburg BL.Reduction of glutathione is associated with growth restriction and enlargement of bovine pulmonary artery endothelial cells produced by transforming growth Factor-1[J].Am J Respir Cell Mol Biol, 1992, 6:364-368
[11] 韩玲,许建英.慢性阻塞性肺疾病患者气道上皮细胞 TGF-β 表达的研究[J].山西医科大学学报,2007,38(1):31-33
[1] Taupin D, Pedersen J,Familari M,et al.Augmented intestinal trefoil factor (TFF3)and loss of pS2 (TFF1)expression precedes metaplastic differentiation of gastric epithelium[J].Lab Invest,2001,81:397-408
[2] Dos Santos SE,Ulrich M,Doring G,et al. Trefoil factor family domain peptides in the human respiratory tract[J].J Pathol,2000,190:133-142
[3] Thim L.Trefoil peptides:from structure to function[J].Cell Mol Life Sci, 1997,53(11-12):888-903
[4] Wiede A, Jagla W, Welte T et al. Localization of TFF3, a new Mucus-associated peptide of the human respiratory tract[J].Am J Respir Crit Care Med 1999, 159:1330-1335
[5] LeSimple P, Seuningen IV,Buisine MP et al.Trefoil Factor Family3 Peptide Promotes Human Airway Epithelial Ciliated Cell Differentiation[J].Am J Respir Cell Mol Biol 2007,(36):296–303
[6] Graness A, Chwieralski CE, Reinhold D,et al. Protein kinase C and ERK activat ion are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion[J].J Biol Chem,2002,277:18440-18446
[1] Ryan JW,Ryan US. Pulmonary endothelial cells[J].Am J Med,1977,63:595
[2] Tierney DF.Intermediary metabolism of the lung[J].Ann Rev Physiol, 1974,36:209
[3] Polak JM,Bloom SR. Peripheral localization of regulatory peptides as a clue to their function[J].J Histochem Cytochem, 1980,28(8):918-924
[4] Ryan JW. Processing of endogenous polypeptides by the lungs[J]. Ann Rev Physiol,1982,44:241-255
[5] Lucchini RE,Facchini F,Turato G,et a1.Increased VIP-positive nerve fibers in the mucous glands of subjects with Chronic bronchitis[J].Am J Respir Crit Care Med,1997,156(6):1963-1968
[6] Groneberg D A,Springer J,Fischer A.Vasoactive intestinal polypeptide as medlater of asthma [J].Pulm Pharmcol Ther,2001,14(5):391-401
[7] Palmer JB. VIP and PHM and their role innonadrenergic inhibitory responses in isolated human airways[J].J appl Physiol,1986,61(4):1322-1328
[8] 伍倩.引经药对P-糖蛋白的影响[J].现代预防医学,2005,32(7):855-856